US20120123026A1 - Functionalized compositions for improved immobilization - Google Patents
Functionalized compositions for improved immobilization Download PDFInfo
- Publication number
- US20120123026A1 US20120123026A1 US12/119,203 US11920308A US2012123026A1 US 20120123026 A1 US20120123026 A1 US 20120123026A1 US 11920308 A US11920308 A US 11920308A US 2012123026 A1 US2012123026 A1 US 2012123026A1
- Authority
- US
- United States
- Prior art keywords
- microspheres
- groups
- entities
- structures
- solid support
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 125000005647 linker group Chemical group 0.000 claims abstract description 59
- 238000010168 coupling process Methods 0.000 claims abstract description 43
- 230000008878 coupling Effects 0.000 claims abstract description 40
- 238000005859 coupling reaction Methods 0.000 claims abstract description 40
- 125000000524 functional group Chemical group 0.000 claims abstract description 29
- 229920000642 polymer Polymers 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 50
- 239000004793 Polystyrene Substances 0.000 claims description 28
- 229920002223 polystyrene Polymers 0.000 claims description 28
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical group C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 22
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 22
- 239000012038 nucleophile Substances 0.000 claims description 20
- 230000000269 nucleophilic effect Effects 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 17
- 239000002105 nanoparticle Substances 0.000 claims description 13
- 239000004065 semiconductor Substances 0.000 claims description 12
- -1 antibody Proteins 0.000 claims description 11
- 239000000412 dendrimer Substances 0.000 claims description 11
- 229920000736 dendritic polymer Polymers 0.000 claims description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 9
- 125000004429 atom Chemical group 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 241000700605 Viruses Species 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000011859 microparticle Substances 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- 229910052717 sulfur Inorganic materials 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 102000004856 Lectins Human genes 0.000 claims description 6
- 108090001090 Lectins Proteins 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 150000004665 fatty acids Chemical class 0.000 claims description 6
- 229910003472 fullerene Inorganic materials 0.000 claims description 6
- 239000002523 lectin Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 239000000178 monomer Substances 0.000 claims description 6
- 239000002071 nanotube Substances 0.000 claims description 6
- 102000005962 receptors Human genes 0.000 claims description 6
- 108020003175 receptors Proteins 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 5
- 239000005909 Kieselgur Substances 0.000 claims description 5
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 5
- 239000011616 biotin Substances 0.000 claims description 5
- 229960002685 biotin Drugs 0.000 claims description 5
- 235000020958 biotin Nutrition 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 239000004927 clay Substances 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 239000006249 magnetic particle Substances 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- 239000004054 semiconductor nanocrystal Substances 0.000 claims description 5
- FVKRBXYHROENKF-UHFFFAOYSA-N 2,3,5,6-tetrafluoro-4-hydroxybenzenesulfonic acid Chemical compound OC1=C(F)C(F)=C(S(O)(=O)=O)C(F)=C1F FVKRBXYHROENKF-UHFFFAOYSA-N 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- 229910021536 Zeolite Inorganic materials 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 229920000620 organic polymer Polymers 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010457 zeolite Substances 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 238000004132 cross linking Methods 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 238000005304 joining Methods 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 150000001805 chlorine compounds Chemical group 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000003367 polycyclic group Chemical group 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 230000001588 bifunctional effect Effects 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 5
- 239000004005 microsphere Substances 0.000 description 161
- 239000007787 solid Substances 0.000 description 77
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 48
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 36
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 31
- 239000000243 solution Substances 0.000 description 29
- 238000006243 chemical reaction Methods 0.000 description 24
- 238000003556 assay Methods 0.000 description 19
- 230000002269 spontaneous effect Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 229920001213 Polysorbate 20 Polymers 0.000 description 11
- 150000001412 amines Chemical class 0.000 description 11
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 11
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 11
- 229940116441 divinylbenzene Drugs 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- 230000003213 activating effect Effects 0.000 description 9
- 239000007987 MES buffer Substances 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 239000007850 fluorescent dye Substances 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- 230000003100 immobilizing effect Effects 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- VMKJWLXVLHBJNK-UHFFFAOYSA-N cyanuric fluoride Chemical compound FC1=NC(F)=NC(F)=N1 VMKJWLXVLHBJNK-UHFFFAOYSA-N 0.000 description 7
- 239000002077 nanosphere Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000009257 reactivity Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 150000003573 thiols Chemical class 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 6
- 0 [1*]C1=C(C)C(=[Y])C1=C.[2*]S(=O)(=O)C=C.[3*]C(=O)OC1=C(F)C(F)=C(S(=O)(=O)[O-])C(F)=C1F.[4*]C1=CC2=C(C=C1)N=C(C)C(C)=N2.[5*]C1=NC(C)=[Y]([Y])C(C)=N1.[6*]C(=O)(=O)F Chemical compound [1*]C1=C(C)C(=[Y])C1=C.[2*]S(=O)(=O)C=C.[3*]C(=O)OC1=C(F)C(F)=C(S(=O)(=O)[O-])C(F)=C1F.[4*]C1=CC2=C(C=C1)N=C(C)C(C)=N2.[5*]C1=NC(C)=[Y]([Y])C(C)=N1.[6*]C(=O)(=O)F 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 229920000344 molecularly imprinted polymer Polymers 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 150000003141 primary amines Chemical class 0.000 description 6
- 238000000527 sonication Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 238000004448 titration Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical compound FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000012736 aqueous medium Substances 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 4
- XWBLQMKBLZTFKQ-UHFFFAOYSA-N CC(=O)NCC(=O)CCCCC(=O)NN.CC1=C(C)C(=O)C1=O Chemical compound CC(=O)NCC(=O)CCCCC(=O)NN.CC1=C(C)C(=O)C1=O XWBLQMKBLZTFKQ-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- IBVAQQYNSHJXBV-UHFFFAOYSA-N adipic acid dihydrazide Chemical compound NNC(=O)CCCCC(=O)NN IBVAQQYNSHJXBV-UHFFFAOYSA-N 0.000 description 3
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 238000011512 multiplexed immunoassay Methods 0.000 description 3
- 238000005935 nucleophilic addition reaction Methods 0.000 description 3
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- PWEBUXCTKOWPCW-UHFFFAOYSA-N squaric acid Chemical compound OC1=C(O)C(=O)C1=O PWEBUXCTKOWPCW-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- YWYKOBFDVHSZRN-UHFFFAOYSA-N CC(=O)Cl.CC(=O)O.NC1=CC=C(S(=O)(=O)O)C=C1 Chemical compound CC(=O)Cl.CC(=O)O.NC1=CC=C(S(=O)(=O)O)C=C1 YWYKOBFDVHSZRN-UHFFFAOYSA-N 0.000 description 2
- JLRZKZKKYFTKTG-UHFFFAOYSA-N CC(=O)Cl.CC(=O)O.NNC1=CC=C(S(=O)(=O)O)C=C1 Chemical compound CC(=O)Cl.CC(=O)O.NNC1=CC=C(S(=O)(=O)O)C=C1 JLRZKZKKYFTKTG-UHFFFAOYSA-N 0.000 description 2
- CHRBNBDJAAGSEX-UHFFFAOYSA-N CC(=O)NC1=CC=C(S(=O)(=O)Cl)C=C1.CC(=O)NC1=CC=C(S(=O)(=O)F)C=C1 Chemical compound CC(=O)NC1=CC=C(S(=O)(=O)Cl)C=C1.CC(=O)NC1=CC=C(S(=O)(=O)F)C=C1 CHRBNBDJAAGSEX-UHFFFAOYSA-N 0.000 description 2
- RWICUQZQDRRCCY-UHFFFAOYSA-N CC(=O)NCC(=O)CCCCC(=O)NCC1=C(F)C(=O)C1=O Chemical compound CC(=O)NCC(=O)CCCCC(=O)NCC1=C(F)C(=O)C1=O RWICUQZQDRRCCY-UHFFFAOYSA-N 0.000 description 2
- 108020003215 DNA Probes Proteins 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- LKJMXPJMEHUVNH-UHFFFAOYSA-N NC1=CC=C2CC(CC(C2=C1)=S(=O)=O)=S(=O)=O.[K] Chemical compound NC1=CC=C2CC(CC(C2=C1)=S(=O)=O)=S(=O)=O.[K] LKJMXPJMEHUVNH-UHFFFAOYSA-N 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000012039 electrophile Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002540 isothiocyanates Chemical class 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 230000005588 protonation Effects 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000002094 self assembled monolayer Substances 0.000 description 2
- 239000013545 self-assembled monolayer Substances 0.000 description 2
- 238000010532 solid phase synthesis reaction Methods 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical group CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- PBYIIRLNRCVTMQ-UHFFFAOYSA-N 2,3,5,6-tetrafluorophenol Chemical compound OC1=C(F)C(F)=CC(F)=C1F PBYIIRLNRCVTMQ-UHFFFAOYSA-N 0.000 description 1
- DPVIABCMTHHTGB-UHFFFAOYSA-N 2,4,6-trichloropyrimidine Chemical compound ClC1=CC(Cl)=NC(Cl)=N1 DPVIABCMTHHTGB-UHFFFAOYSA-N 0.000 description 1
- NTSYSQNAPGMSIH-UHFFFAOYSA-N 2,4,6-trifluoropyrimidine Chemical compound FC1=CC(F)=NC(F)=N1 NTSYSQNAPGMSIH-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical class C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- JCEZOHLWDIONSP-UHFFFAOYSA-N 3-[2-[2-(3-aminopropoxy)ethoxy]ethoxy]propan-1-amine Chemical compound NCCCOCCOCCOCCCN JCEZOHLWDIONSP-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- AQSIKDCOGZGZFV-UHFFFAOYSA-M C.C.CC(=O)NCC(=O)CCCCC(=O)NCC1=C(F)C(=O)C1=O.CCCCOC1=C(CNC(=O)CCCCC(=O)CNC(C)=O)C(=O)C1=O.FC1=NC(F)=NC(F)=N1.O[Na] Chemical compound C.C.CC(=O)NCC(=O)CCCCC(=O)NCC1=C(F)C(=O)C1=O.CCCCOC1=C(CNC(=O)CCCCC(=O)CNC(C)=O)C(=O)C1=O.FC1=NC(F)=NC(F)=N1.O[Na] AQSIKDCOGZGZFV-UHFFFAOYSA-M 0.000 description 1
- LZIJSGANWRSHNU-UHFFFAOYSA-M C.C.CC(=O)NCC(=O)CCCCC(=O)NCC1=C(O)C(=O)C1=O.CCCCOC1=C(CNC(=O)CCCCC(=O)CNC(C)=O)C(=O)C1=O.O[Na] Chemical compound C.C.CC(=O)NCC(=O)CCCCC(=O)NCC1=C(O)C(=O)C1=O.CCCCOC1=C(CNC(=O)CCCCC(=O)CNC(C)=O)C(=O)C1=O.O[Na] LZIJSGANWRSHNU-UHFFFAOYSA-M 0.000 description 1
- HCJSMNZBFBMGDC-UHFFFAOYSA-M C.C.CCCCOC1=C(CNC(=O)CCCCC(=O)CNC(C)=O)C(=O)C1=O.CCCC[N+](CCCC)(CCCC)CCCC.O[Na].[OH-] Chemical compound C.C.CCCCOC1=C(CNC(=O)CCCCC(=O)CNC(C)=O)C(=O)C1=O.CCCC[N+](CCCC)(CCCC)CCCC.O[Na].[OH-] HCJSMNZBFBMGDC-UHFFFAOYSA-M 0.000 description 1
- ALRMSOVZOATHHP-UHFFFAOYSA-M C.C.CCCCOC1=C(CNC(=O)CCCCC(=O)CNC(C)=O)C(=O)C1=O.CN(C)C(F)=[N+](C)C.F[P-](F)(F)(F)(F)F.O[Na] Chemical compound C.C.CCCCOC1=C(CNC(=O)CCCCC(=O)CNC(C)=O)C(=O)C1=O.CN(C)C(F)=[N+](C)C.F[P-](F)(F)(F)(F)F.O[Na] ALRMSOVZOATHHP-UHFFFAOYSA-M 0.000 description 1
- LADYRFSPKMBLBS-UHFFFAOYSA-M C.C=CS(=O)(=O)CCSCCNC(C)=O.CC(=O)NCCSCCS(=O)(=O)CCSS(=O)(=O)[O-].O=S=S(=O)=O.[Na+].[Na][Na] Chemical compound C.C=CS(=O)(=O)CCSCCNC(C)=O.CC(=O)NCCSCCS(=O)(=O)CCSS(=O)(=O)[O-].O=S=S(=O)=O.[Na+].[Na][Na] LADYRFSPKMBLBS-UHFFFAOYSA-M 0.000 description 1
- WXWCRUGISVSNMZ-UHFFFAOYSA-N C.CC(=O)CN(CCN(CC(C)=O)CC(=O)O)CCN(CC(C)=O)CC(=O)O Chemical compound C.CC(=O)CN(CCN(CC(C)=O)CC(=O)O)CCN(CC(C)=O)CC(=O)O WXWCRUGISVSNMZ-UHFFFAOYSA-N 0.000 description 1
- MHFZXNXEOZXBQR-UHFFFAOYSA-N C.CC(=O)CNC1=CC=C(S(=O)(=O)O)C=C1.CC(=O)NCC1=CC=C(S(=O)(=O)F)C=C1.FC1=NC(F)=NC(F)=N1 Chemical compound C.CC(=O)CNC1=CC=C(S(=O)(=O)O)C=C1.CC(=O)NCC1=CC=C(S(=O)(=O)F)C=C1.FC1=NC(F)=NC(F)=N1 MHFZXNXEOZXBQR-UHFFFAOYSA-N 0.000 description 1
- KFFJKPCVSWJVLL-UHFFFAOYSA-N C=CS(=O)(=O)C=C.C=CS(=O)(=O)CCOCCNC(C)=O.CC(=O)NCCO.CCCC[O-].ClCCl.[Na+] Chemical compound C=CS(=O)(=O)C=C.C=CS(=O)(=O)CCOCCNC(C)=O.CC(=O)NCCO.CCCC[O-].ClCCl.[Na+] KFFJKPCVSWJVLL-UHFFFAOYSA-N 0.000 description 1
- YTDIOVSMXITQDT-UHFFFAOYSA-N C=CS(=O)(=O)C=C.C=CS(=O)(=O)CCSCCNC(C)=O.CC(=O)NCCS Chemical compound C=CS(=O)(=O)C=C.C=CS(=O)(=O)CCSCCNC(C)=O.CC(=O)NCCS YTDIOVSMXITQDT-UHFFFAOYSA-N 0.000 description 1
- ZISITDMIXMGFBA-UHFFFAOYSA-N C=O.CCC(F)(F)C(F)(F)OC(F)(F)C(F)(F)CC Chemical compound C=O.CCC(F)(F)C(F)(F)OC(F)(F)C(F)(F)CC ZISITDMIXMGFBA-UHFFFAOYSA-N 0.000 description 1
- RULFDEHADAWZGZ-UHFFFAOYSA-N C=O.CCCCCCC Chemical compound C=O.CCCCCCC RULFDEHADAWZGZ-UHFFFAOYSA-N 0.000 description 1
- OIOIHJPGZFMPKM-UHFFFAOYSA-N C=O.CCCCCCCCC Chemical compound C=O.CCCCCCCCC OIOIHJPGZFMPKM-UHFFFAOYSA-N 0.000 description 1
- LJPLVNWRNWTCHI-UHFFFAOYSA-N C=O.CCCCCOCCCC Chemical compound C=O.CCCCCOCCCC LJPLVNWRNWTCHI-UHFFFAOYSA-N 0.000 description 1
- CMBOEHVTEIHVFT-UHFFFAOYSA-N C=O.CCCCN(CC)CC.O=P(=O)OO Chemical compound C=O.CCCCN(CC)CC.O=P(=O)OO CMBOEHVTEIHVFT-UHFFFAOYSA-N 0.000 description 1
- OTYAENXJWGDXIE-UHFFFAOYSA-N CC(=O)C(CCC(C)C(=O)O)CC(C)C(=O)O Chemical compound CC(=O)C(CCC(C)C(=O)O)CC(C)C(=O)O OTYAENXJWGDXIE-UHFFFAOYSA-N 0.000 description 1
- JMPKOXVEVDCWNI-UHFFFAOYSA-L CC(=O)Cl.CC(=O)NC1=CC2=C(C=C1)C=C(S(=O)(=O)F)C=C2S(=O)(=O)F.FC1=NC(F)=NC(F)=N1.NC1=CC2=C(C=C1)C(S(=O)(=O)O[K])=CC(S(=O)(=O)O[K])=C2 Chemical compound CC(=O)Cl.CC(=O)NC1=CC2=C(C=C1)C=C(S(=O)(=O)F)C=C2S(=O)(=O)F.FC1=NC(F)=NC(F)=N1.NC1=CC2=C(C=C1)C(S(=O)(=O)O[K])=CC(S(=O)(=O)O[K])=C2 JMPKOXVEVDCWNI-UHFFFAOYSA-L 0.000 description 1
- ODQSKIQYZNTXHN-UHFFFAOYSA-L CC(=O)Cl.CC(=O)NC1=CC2=C(C=C1)C=C(S(=O)(=O)F)C=C2S(=O)(=O)F.NC1=CC2=C(C=C1)C(S(=O)(=O)O[K])=CC(S(=O)(=O)O[K])=C2 Chemical compound CC(=O)Cl.CC(=O)NC1=CC2=C(C=C1)C=C(S(=O)(=O)F)C=C2S(=O)(=O)F.NC1=CC2=C(C=C1)C(S(=O)(=O)O[K])=CC(S(=O)(=O)O[K])=C2 ODQSKIQYZNTXHN-UHFFFAOYSA-L 0.000 description 1
- NCUNEYSBEQIOGJ-UHFFFAOYSA-L CC(=O)Cl.CC(=O)O.NC1=CC2=C(C=C1)C(S(=O)(=O)O[K])=CC(S(=O)(=O)O[K])=C2 Chemical compound CC(=O)Cl.CC(=O)O.NC1=CC2=C(C=C1)C(S(=O)(=O)O[K])=CC(S(=O)(=O)O[K])=C2 NCUNEYSBEQIOGJ-UHFFFAOYSA-L 0.000 description 1
- XWARGIWMQHTXKA-UHFFFAOYSA-N CC(=O)Cl.CC(=O)O.NCCCC1=CC=CC2=C1C=CC=C2S(=O)(=O)O Chemical compound CC(=O)Cl.CC(=O)O.NCCCC1=CC=CC2=C1C=CC=C2S(=O)(=O)O XWARGIWMQHTXKA-UHFFFAOYSA-N 0.000 description 1
- UYUYUXKGHPJHNJ-UHFFFAOYSA-L CC(=O)NC1=CC2=C(C=C1)C=C(S(=O)(=O)Cl)C=C2S(=O)(=O)Cl.CC(=O)NC1=CC2=C(C=C1)C=C(S(=O)(=O)O[K])C=C2S(=O)(=O)O[K] Chemical compound CC(=O)NC1=CC2=C(C=C1)C=C(S(=O)(=O)Cl)C=C2S(=O)(=O)Cl.CC(=O)NC1=CC2=C(C=C1)C=C(S(=O)(=O)O[K])C=C2S(=O)(=O)O[K] UYUYUXKGHPJHNJ-UHFFFAOYSA-L 0.000 description 1
- BYFOLYKWRTUXOS-UHFFFAOYSA-N CC(=O)NC1=CC=C(S(=O)(=O)Cl)C=C1.CC(=O)NC1=CC=C(S(=O)(=O)O)C=C1 Chemical compound CC(=O)NC1=CC=C(S(=O)(=O)Cl)C=C1.CC(=O)NC1=CC=C(S(=O)(=O)O)C=C1 BYFOLYKWRTUXOS-UHFFFAOYSA-N 0.000 description 1
- ZQPVMSLLKQTRMG-UHFFFAOYSA-N CC(=O)NC1=CC=C(S(=O)(=O)O)C=C1 Chemical compound CC(=O)NC1=CC=C(S(=O)(=O)O)C=C1 ZQPVMSLLKQTRMG-UHFFFAOYSA-N 0.000 description 1
- WRQQQGCTULDAOQ-UHFFFAOYSA-L CC(=O)NCC(=O)CCCCC(=O)NCC1=C([O-])C(=O)C1=O.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.[F-] Chemical compound CC(=O)NCC(=O)CCCCC(=O)NCC1=C([O-])C(=O)C1=O.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.[F-] WRQQQGCTULDAOQ-UHFFFAOYSA-L 0.000 description 1
- WYTKYULPRDNHST-UHFFFAOYSA-N CC(=O)NCCCCCN.CCCCCNC(C)=O.FC1=NC(F)=NC(F)=N1.NC1=NC(F)=NC(F)=N1 Chemical compound CC(=O)NCCCCCN.CCCCCNC(C)=O.FC1=NC(F)=NC(F)=N1.NC1=NC(F)=NC(F)=N1 WYTKYULPRDNHST-UHFFFAOYSA-N 0.000 description 1
- MTDLQWOSKRXEOW-UHFFFAOYSA-N CC(=O)NNC1=CC=C(S(=O)(=O)Cl)C=C1.CC(=O)NNC1=CC=C(S(=O)(=O)O)C=C1 Chemical compound CC(=O)NNC1=CC=C(S(=O)(=O)Cl)C=C1.CC(=O)NNC1=CC=C(S(=O)(=O)O)C=C1 MTDLQWOSKRXEOW-UHFFFAOYSA-N 0.000 description 1
- XHGAREMGFCPXDR-BHAAXKIKSA-N CC(=O)NSSCCN.CC(=O)O.NCCSSCCN.[2H][3H].[3HH] Chemical compound CC(=O)NSSCCN.CC(=O)O.NCCSSCCN.[2H][3H].[3HH] XHGAREMGFCPXDR-BHAAXKIKSA-N 0.000 description 1
- SDDIRQNDDGZTNS-UHFFFAOYSA-M CC(=O)O.CC(=O)OC1=C(F)C(F)=C(S(=O)(=O)[O-])C(F)=C1F.O=S(=O)(O)C1=C(F)C(F)=C(O)C(F)=C1F Chemical compound CC(=O)O.CC(=O)OC1=C(F)C(F)=C(S(=O)(=O)[O-])C(F)=C1F.O=S(=O)(O)C1=C(F)C(F)=C(O)C(F)=C1F SDDIRQNDDGZTNS-UHFFFAOYSA-M 0.000 description 1
- UKDGFKOIKBREHG-UHFFFAOYSA-N CC.CC(=O)NCCCC1=CC=CC2=C1C=CC=C2S(=O)(=O)Cl.CC(=O)NCCCC1=CC=CC2=C1C=CC=C2S(=O)(=O)O Chemical compound CC.CC(=O)NCCCC1=CC=CC2=C1C=CC=C2S(=O)(=O)Cl.CC(=O)NCCCC1=CC=CC2=C1C=CC=C2S(=O)(=O)O UKDGFKOIKBREHG-UHFFFAOYSA-N 0.000 description 1
- AHKRBLAMOLUVKL-UHFFFAOYSA-N CCC(=O)C(C)NC Chemical compound CCC(=O)C(C)NC AHKRBLAMOLUVKL-UHFFFAOYSA-N 0.000 description 1
- MBUWULYTBJAWCU-UHFFFAOYSA-N CCCCOC1=C(CNC(=O)CCCCC(=O)CNC(C)=O)C(=O)C1=O Chemical compound CCCCOC1=C(CNC(=O)CCCCC(=O)CNC(C)=O)C(=O)C1=O MBUWULYTBJAWCU-UHFFFAOYSA-N 0.000 description 1
- JGZOXXYLBMYJPA-UHFFFAOYSA-N CNC(=O)CNC1=C(NC(=O)NC2=C(NC(=O)NC)C(=O)C2=O)C(=O)C1=O Chemical compound CNC(=O)CNC1=C(NC(=O)NC2=C(NC(=O)NC)C(=O)C2=O)C(=O)C1=O JGZOXXYLBMYJPA-UHFFFAOYSA-N 0.000 description 1
- XRVHSOXXNQTWAW-UHFFFAOYSA-N CNC(=O)NC(C)=O Chemical compound CNC(=O)NC(C)=O XRVHSOXXNQTWAW-UHFFFAOYSA-N 0.000 description 1
- XOYSQXNEFMJNOD-UHFFFAOYSA-N CNC(CNC(C(C1=O)=O)=C1NC(CNC(C(C1=O)=O)=C1NC(NC)=O)=O)=O Chemical compound CNC(CNC(C(C1=O)=O)=C1NC(CNC(C(C1=O)=O)=C1NC(NC)=O)=O)=O XOYSQXNEFMJNOD-UHFFFAOYSA-N 0.000 description 1
- JJCGEEMKEKJXQC-UHFFFAOYSA-N CNCCNC(=O)CCN(CCNC(=O)CCN(CCNC(C)=O)CCC(=O)NCCCCCC(=O)NC)CCC(=O)NCCNC Chemical compound CNCCNC(=O)CCN(CCNC(=O)CCN(CCNC(C)=O)CCC(=O)NCCCCCC(=O)NC)CCC(=O)NCCNC JJCGEEMKEKJXQC-UHFFFAOYSA-N 0.000 description 1
- JGMDFIGSZCXUBT-UHFFFAOYSA-N CNCCNCCN(CCNCCN(CCN)CCN)CCNCCN(CCN)CCNC Chemical compound CNCCNCCN(CCNCCN(CCN)CCN)CCNCCN(CCN)CCNC JGMDFIGSZCXUBT-UHFFFAOYSA-N 0.000 description 1
- FCYWXWHFSYKBRH-UHFFFAOYSA-N CNNC(=O)CCCCC(=O)NNC Chemical compound CNNC(=O)CCCCC(=O)NNC FCYWXWHFSYKBRH-UHFFFAOYSA-N 0.000 description 1
- MWOYHULGIYMLCD-UHFFFAOYSA-N CNNS(=O)(=O)CCCCS(=O)(=O)NNC Chemical compound CNNS(=O)(=O)CCCCS(=O)(=O)NNC MWOYHULGIYMLCD-UHFFFAOYSA-N 0.000 description 1
- WBIVMLBGZGMDFX-UHFFFAOYSA-N CNNS(=O)(=O)NNC Chemical compound CNNS(=O)(=O)NNC WBIVMLBGZGMDFX-UHFFFAOYSA-N 0.000 description 1
- FRWWFTAMDTVHKA-UHFFFAOYSA-N CNS(=O)(=O)CCS(=O)(=O)NC Chemical compound CNS(=O)(=O)CCS(=O)(=O)NC FRWWFTAMDTVHKA-UHFFFAOYSA-N 0.000 description 1
- GLJYXCHBQTXTFP-RGURZIINSA-N C[C@@H](CCC1)C1C(NNC(CCCCC(NNC(C(C1=O)=O)=C1O)=O)=O)=O Chemical compound C[C@@H](CCC1)C1C(NNC(CCCCC(NNC(C(C1=O)=O)=C1O)=O)=O)=O GLJYXCHBQTXTFP-RGURZIINSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical class [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- VBKKVDGJXVOLNE-UHFFFAOYSA-N Dioxation Chemical compound CCOP(=S)(OCC)SC1OCCOC1SP(=S)(OCC)OCC VBKKVDGJXVOLNE-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- SJQRQOKXQKVJGJ-UHFFFAOYSA-N NCCNc1c(cccc2S(O)(=O)=O)c2ccc1 Chemical compound NCCNc1c(cccc2S(O)(=O)=O)c2ccc1 SJQRQOKXQKVJGJ-UHFFFAOYSA-N 0.000 description 1
- IOMZCWUHFGMSEJ-UHFFFAOYSA-N NNc(cc1)ccc1S(O)(=O)=O Chemical compound NNc(cc1)ccc1S(O)(=O)=O IOMZCWUHFGMSEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- PZUCUUKGJKCHHX-UHFFFAOYSA-N [H]N(C(=O)C(C)=O)N([H])S(=O)(=O)N([H])N([H])C(=O)C(C)=O Chemical compound [H]N(C(=O)C(C)=O)N([H])S(=O)(=O)N([H])N([H])C(=O)C(C)=O PZUCUUKGJKCHHX-UHFFFAOYSA-N 0.000 description 1
- BMDQHRHXDXOXEF-UHFFFAOYSA-M [O-]C(C(C1=O)=O)=C1NNC(CCCCC(NNC(C1CCC1)=O)=O)=O Chemical compound [O-]C(C(C1=O)=O)=C1NNC(CCCCC(NNC(C1CCC1)=O)=O)=O BMDQHRHXDXOXEF-UHFFFAOYSA-M 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001265 acyl fluorides Chemical class 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001718 carbodiimides Chemical group 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- LNGNZSMIUVQZOX-UHFFFAOYSA-L disodium;dioxido(sulfanylidene)-$l^{4}-sulfane Chemical compound [Na+].[Na+].[O-]S([O-])=S LNGNZSMIUVQZOX-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000005694 halopyrimidines Chemical class 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000009149 molecular binding Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229940044654 phenolsulfonic acid Drugs 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 239000000985 reactive dye Substances 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012475 sodium chloride buffer Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- XBRWELTXMQSEIN-UHFFFAOYSA-N squaric acid dibutyl ester Chemical compound CCCCOC1=C(OCCCC)C(=O)C1=O XBRWELTXMQSEIN-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000000979 synthetic dye Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/28—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
- C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/18—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by addition of thiols to unsaturated compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/22—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- C07C381/02—Thiosulfates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
Definitions
- the present invention relates to improved covalent coupling of two or more entities such as biomolecules, polymer compositions, organic/inorganic molecules/materials, and the like, including their combinations, through one or more novel reactive groups attached to linker groups of 2-1000 atoms length.
- the immobilization of entities can be achieved by simple covalent reaction with an activated solid surface.
- particles e.g., micro- and nano-spheres; metal particles comprised of one or more metals with any size, shape, or composition; semiconductor particles, molecularly imprinted polymers (MIPS), magnetic particles; or dyed materials
- microtiter plates are a common solid matrix in many immobilization systems. Preparing and maintaining the active, functionalized surface is an important factor to assure immobilization of sufficient biological material for development of a sensitive assay.
- Current immobilization procedures of biomolecules on solid surfaces generally involve reactions of an activated amino or carboxyl group derivatized solid surface with amino- or thiol-modified biomolecules. After activation, or after introduction of a functionalized spacer, these groups offer direct attachment sites. Most of these functional groups (such as NHS esters, isothiocyanates, etc.) are prone to hydrolysis in an aqueous environment and become non-reactive (i.e., chemically inactive) in a matter of less than an hour.
- functional groups such as NHS esters, isothi
- Reactive or functionalized microspheres are conventionally produced via copolymerization of suitably functionalized monomers, or via post-chemical modification of preformed microspheres.
- Post-functionalization is a popular method for preparing reactive particles as earlier described by Upson (J. Polym. Sci., Polym. Symp. 1985, 72, 45).
- the most frequently used method to immobilize biomolecules (such as oligonucleotides, proteins, or carbohydrates) onto fluorescent microspheres is by activating surface carboxy groups.
- the activation requires excess EDC and a coupling pH of 4 to 6.
- the reaction involves the intermediate formation of an activated O-acylurea derivative between the carbodiimide and carboxyl functions.
- a subsequent nucleophilic attack by the primary nitrogen of the amino-groups of the biomolecule brings about the formation of the amide linkage with the release of the substituted urea.
- the optimum pH for the formation of O-acylurea is about pH 4-5.
- the intermediate has an extremely short half-life and rapidly undergoes hydrolysis or rearranges to give the N-acylurea adduct.
- the primary amino group of the nucleophile is predominantly protonated at about pH 4-5 and is thus mostly unreactive. These limitations can severely restrict coupling yields. At low pH, the nucleic acid bases undergo intensive protonation. Such type of protonation induces a DNA melting that exposes the hydrophobic core of the helix, enhancing nonspecific hydrophobic interactions with the solid matrix. Despite these drawbacks, EDC-mediated coupling currently is the major mode of covalent immobilization of biomolecules to solid surfaces (Hermanson, G. T. in Bioconjugate Techniques, Academic Press; N.Y. 1996; Andreas Frey et. al., Bioconjugate Chem. 1999, 10, 562-71; Maxime A. Gilles et. al., Anal.
- the present invention is based, at least in part, upon improved methods and compositions for covalent coupling of two or more entities (B, B′, etc.) such as biomolecules, polymer compositions, organic and/or inorganic molecules and/or materials, etc., through one or more “novel reactive groups” (Structures 1-6).
- entities such as biomolecules, polymer compositions, organic and/or inorganic molecules and/or materials, etc.
- Entities B, B′, etc., under the present invention comprise, but are not limited to, glass, quartz, monomer, polymer, dendrimer, MIPS, membranes, metal, clay, diatomaceous earth, particle (dyed or undyed), particle (magnetic or non-magnetic), particle (micro- or nanospheres), fullerenes, nanotubes, biomolecule, chromophore, fluorophore, chemiluminescent compound, semiconductor particles, semiconductor nanocrystals (quantum dots), J- or H-aggregates, cells, organisms, bacteria, viruses, or any combination thereof.
- Entities B, B′, etc. can be the same or different, and can be functionalized or non-functionalized.
- novel reactive groups of the present invention are conjugated to entities B, B′, etc., by way of a linker, (L) n , where L is a hydrocarbon linker with n number of atoms (e.g., 2 to 1000) of H, C, O, N, Si, P and S in straight or branched chains, rings, or combinations thereof.
- L is a hydrocarbon linker with n number of atoms (e.g., 2 to 1000) of H, C, O, N, Si, P and S in straight or branched chains, rings, or combinations thereof.
- one or more entities B, B′, etc. are nucleophile-containing entities, i.e., they contain hydroxyl, amine, thiol, etc., groups, or the entities are conjugated to such groups.
- attachment of the novel reactive groups may be accomplished by the chemical reaction of the electrophilic reactive group of one or more of Structures 1-6 with the nucleophilic group contained on or within the entity.
- Such chemical reactions include, but are not limited to, nucleophilic addition or nucleophilic-based reaction known to a person of ordinary skill in the art, substitution and/or displacement.
- a reaction of the present invention whereby two entities, B and B′, are cross-linked via one or more of Structures 1-6.
- Any nucleophile- or electrophile-containing groups are termed A, A′, etc., where A and/or A′ are a novel reactive group, or combination thereof, discussed in the present invention and/or a nucleophile (e.g., alcohol, amine, thiol, etc.), respectively.
- a and A′ can be the same or different novel reactive group and/or the same or different nucleophile.
- B and B′ can either be the same and/or different entities.
- one entity B a polymeric microsphere
- an electrophile-containing group of one of Structures 1-6 through the group's respective linker R 1 -R 6 .
- a second entity, B′ a semiconductor nanoparticle, is conjugated with a nucleophilic group at its surface.
- a straightforward nucleophilic substitution reaction results in the linking of B with B′ by way of the linker.
- a bifunctional linker or bridge molecule is used to covalently couple the two or more entities.
- the bifunctionality of the linker is nucleophilic (e.g., amine, thiol, etc.).
- the bridge molecule contains two or more nucleophilic groups, one of which reacts with each of A and A′ such that B and B′ are linked through the combined length of the linker arms of A and A′ and the length of the bridge molecule.
- B and B′ contain A and A′, respectively, which are both nucleophiles.
- a bifunctional linker or bridge molecule is used to couple the two or more entities whereby the bifunctionality of the linker or bridge molecule are one or more novel electrophilic reactive groups of Structures 1-6, where those groups can be the same or different novel reactive groups.
- the bridge molecule may or may not be constructed by joining the free ends of the linkers R 1 -R 6 of the respective electrophilic reactive groups of Structures 1-6. Following the reaction of these elements, B and B′ are linked via the bifunctional bridge molecule binding covalently to their respective nucleophilic groups.
- a bifunctional linker or bridge molecule is used to couple the two or more entities wherein C and/or C′ are a functional group or groups (e.g., NHS ester, isothiocyanate, sulfonyl chloride, etc.) known to react with nucleophiles A and A′.
- C and C′ can be the same or different functional groups which are attached to the linker or bridge molecule by way of one or more (n) novel electrophilic reactive groups of Structures 1-6 where n is the number of novel electrophilic reactive groups.
- compositions comprising one or more, in any combination, of Structures 1-6:
- the present invention is directed to novel compositions as described above wherein R 1 -R 6 contain 2-100 atoms, or more preferably wherein R 1 -R 6 contain 2-10 atoms.
- compositions comprising the Structures 1-6 noted above, wherein R 1 -R 6 comprise hydrocarbon linker groups containing, optionally, one or more halogen or heteroatoms selected from the group consisting of O, N, Si, P and S; in straight or branched chains, rings, or combinations thereof containing from 2-1000 atoms, preferably 2-100 atoms, or more preferably wherein R 1 -R 6 contain 2-10 atoms.
- the present invention also is directed toward compositions as described above wherein B is a polymeric microsphere or nanosphere. Even more preferred is an embodiment wherein the polymeric microsphere further comprises polystyrene/divinyl benzene and/or carboxyl functional groups at least on its surface, and even more preferred is an embodiment wherein the microsphere further comprises one or more fluorescent dyes in distinguishable ratios.
- the present invention relates, in a preferred embodiment, to functionalized microspheres.
- a series of reactive functional groups has been evaluated on polystyrene-based microspheres for their ability to immobilize biomolecules, which biomolecules comprise prokaryotic or eukaryotic cells, transgenic cells, organisms, bacteria, viruses, plasmids, expression vectors, enzymes, proteins, fusion proteins, antibodies, chimeric antibodies, DNA, RNA, PNA, fatty acids, lectins, peptides, and receptors, or any combination thereof.
- Activated oxocarbon acids e.g., mono-fluoro squaric acid (MFS)), tetra-fluoro-sulfophenyl ester (TFS), vinyl sulfone (VS), dihaloquinoxaline, sulfonyl fluoride, cyanuric acid halide and halopyrimidine show improved performance for immobilizing biomolecules as they (a) spontaneously react with nucleophilic groups of biomolecules, (b) show substantially improved stability in aqueous media, (c) form stable conjugates with biomolecules, (d) require no additional activating reagents and (e) may provide more specific conjugation (i.e., reduced nonspecific interaction/binding with solid substrates) thus protecting the integrity of the biomolecule.
- MFS mono-fluoro squaric acid
- TFS tetra-fluoro-sulfophenyl ester
- VS vinyl sulfone
- dihaloquinoxaline
- a novel reactive group can be attached first to a biomolecule and then coupled to a solid support containing nucleophilic groups. Also disclosed are new linker systems aimed at improving the coupling yields of biomolecules to solid surfaces.
- the present invention is directed toward a method for coupling two or more entities together by providing one or more conjugate compositions as described above having one or more, in any combination, of Structures 1-6 connected through their respective linker groups, R 1 -R 6 , to at least one entity B; providing one or more nucleophile-containing entities comprised of:
- the present invention encompasses a method for the synthesis of compositions noted above wherein the one or more, in any combination, of Structures 1-6 are conjugated to the entity B before the fabrication of the entity B; during the fabrication of the entity B; or after the fabrication of entity B.
- Another preferred embodiment of the present invention is directed toward a method of crosslinking one or more nucleophile-containing entities comprising reacting a composition of Structure 1, as described above, wherein:
- the present invention is directed toward the use of Structures 1-6 in the creation of bridge molecules for linking two or more entities together, or compositions comprising one or more of Structures 1-6 as bridge molecules.
- Various embodiments of the present invention include multifunctional bridge molecules of two or more of Structures 1-6 joined through their respective linker groups R 1 -R 6 , in an end-to-end fashion, in a branched chain, or in dendritic fashion.
- Such bridge molecules may be used to link together covalently two or more entities having nucleophilic groups by straightforward chemical reactions such as nucleophilic addition or substitution or any other applicable chemical reaction known to a person of ordinary skill in the art.
- a multifunctional bridge molecule wherein the functional groups are one of more of Structures 1-6 and one or more nucleophilic groups.
- Such bridge molecules may be used to link together covalently one or more entities having nucleophilic groups with one or more entities conjugated to one or more of Structures 1-6 by straightforward chemical reactions such as nucleophilic addition or substitution, wherein the entity(ies) having nucleophilic groups react with the bridge group, functionality(ies) of Structures 1-6, and the entity(ies) having reactive groups of Structures 1-6 react with the nucleophilic bridge group functionality(ies) to yield two or more entities linked together.
- a bridge group composition is envisioned wherein one or more of Structures 1-6, in any combination, are conjugated by their respective linker groups R 1 -R 6 to one or more nucleophilic groups, wherein if two or more of Structure 1-6 are joined together, they are joined together through their respective linker groups R 1 -R 6 , wherein the joining is one or more of end-to-end, branched, or dendritic, in any combination.
- FIG. 1 shows a comparison of the COOH-functionalized microsphere, EDC coupling method (A) to mono-fluoro squaric acid-functionalized microspheres (MFS) (B) over time (accelerated at 25° C.).
- the novel pre-activated microspheres (B) provide more reproducible coupling day-to-day than the standard EDC-mediated reactions (A).
- FIG. 2 shows a stability study of vinyl sulfone (VS)-functionalized microspheres stored in buffer, pH 6 at 4° C.
- FIG. 3 shows an accelerated stability study of mono-fluoro squaric acid (MFS)-functionalized microspheres stored dry.
- FIG. 4 shows an accelerated stability study of mono-fluoro squaric acid (MFS)-functionalized microspheres stored dry over a longer time period than shown in FIG. 3 .
- MFS mono-fluoro squaric acid
- FIG. 5 shows an accelerated stability study of tetra-fluoro-sulfophenyl ester (TFS)-functionalized microspheres stored dry.
- FIG. 6 shows an accelerated stability study of vinyl sulfone (VS)-functionalized microspheres stored dry.
- FIG. 7 shows a coupling titration of an amino-functionalized DNA probe on (A) COOH-functionalized microspheres (EDC-mediated reaction) vs. (B) mono-fluoro squaric acid (MFS)-functionalized microspheres (spontaneous reaction) methods. Both coupling titrations were performed at 25° C. The DNA compliment target concentration for the assay was 20 fmoles at a hybridization temperature of 55° C. The COOH-EDC method (A) yields a non-linear response to the amount of probe coupled to the microspheres. The mono-fluoro squaric acid-functionalized microsphere's probe titration (B) is more linear. These results are reproducible and may be the result of a more specific coupling. Note: 25° C. is not an optimal coupling temperature for the mono-fluoro squaric acid-functionalized microspheres. Signal is expected to improve with optimization of all parameters.
- Sulfonyl fluorides are known to be more stable in an aqueous environment than sulfonyl chlorides (Table 1, 1a-1d) and the aromatic versions are more stable as compared to their aliphatic counter parts.
- Several routes starting either from acids or acid chlorides were used to synthesize sulfonyl fluorides (Table 1, 2a-2e) on the surface of polystyrene microspheres.
- the cyclic oxo-carbon acids (deltic, squaric, croconic and rhodizonic) have two acid equivalents and 1-4 carbonyl groups in a ring.
- the inventors have used one of the acid equivalents to connect the ring to one of our linker molecules and activated the other to a reactive derivative.
- Several routes to synthesize squaric acid derivatized microspheres are provided in Table 1 (3a-3e).
- the resulting activated beads are very reactive with amine containing molecules and can be stored on a long term basis if kept dry. This class of reactive group can also be used as a replacement for NHS esters and the like to activate dyes and biomolecules.
- Cyanuric fluoride can react with up to three equivalents of amine, replacing the fluorine atoms with the nitrogen atoms of the amines.
- the inventors have isolated microspheres in which cyanuric fluoride was reacted with one equivalent of an amine linker, which was attached to a microsphere (Table 1, 4).
- the second and third fluorine are still available for reaction with bio-molecules.
- Related molecules such as cyanuric chloride, 2,4,6-trichloro pyrimidine or 2,4,6-trifluoropyrimidine are used similarly.
- Vinyl sulfone (VS) microspheres were generated by reacting divinyl sulfone with microspheres containing hydroxy, amino or thiol groups (Table 1, 5a-5b). The remaining vinyl moiety is available for reaction with both thiols and amines. This group is less susceptible to hydrolysis, but requires a basic pH for reaction with amines.
- the vinyl sulfone (VS) group can be protected from oxidation during long term storage by reacting it with sodium thiosulfate as in Table 1, 5c. The vinyl moiety is regenerated at about pH 9-10.
- Perfluorinated phenols have been developed as hydrolysis resistant replacements for N-hydroxysuccinimide for conventional coupling chemistries.
- the inventors reacted tetrafluoro-phenolsulfonic acid with carboxylic acid groups directly on the surface of microspheres (Table 1, 6) or on the end of a linker molecule.
- Fluorine atoms provide the moiety with a good leaving group and the sulfonic acid maintains the charge on the surface of the microsphere, which is needed to disperse it in water.
- microsphere charge The overall performance of a functionalized microsphere is controlled by several parameters—microsphere charge, density of cross-linking, location, accessibility and chemical stability of functional groups, length, charge and nature of the linker group.
- Linkers play an important role in bioconjugations. They are selected based not only on their length, but their chemical nature. The overall nature of the linker is known to govern the overall hydrophilicity or hydrophobicity of the reagent environment. It is well understood that extended linkers can reduce the steric interferences between the analyte and the solid matrix.
- linkers could be used to connect the above mentioned functional groups to microspheres. Examples of these linkers are shown in Table 2.
- Ethylene glycol based linkers (Table 2, 1-3) are surface modifiers which are known for improving the stability of hydrophilic surfaces. Additional stability is ensured by replacing CH 2 with CF 2 .
- Straight chain polymethylenes (Table 2, 4) are other linkers that may be used to connect the above mentioned functional groups to microspheres.
- Diamines and hydrazides are known to provide hydrophobic surfaces (Table 2, 5-8).
- Polyethylenimines (Table 2, 9) exhibit a ‘proton sponge’ effect, which can be used to control the surface charge of the microsphere.
- Polyamides and polysulfonamides (Table 2, 10-13) contain acidic protons with a pKa of about 1-2. These linkers, therefore, provide polyanions at physiological pH and hence provide long storage stability.
- Dendrimers or highly branched linkers (Table 2, 14) are known to adopt to well defined morphologies and provide a kind of encapsulation to the reactive groups and hence protect them from hydrolysis.
- DTPA diethylene triamine pentaacetic acid linkers
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, microspheres for covalent immobilization of biomolecules.
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, microspheres for covalent immobilization of biomolecules.
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, microspheres for covalent immobilization of biomolecules.
- This example relates to, but is not limited to, the use of a solid surface for covalent immobilization of functionalized, or pre-activated biomolecules.
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, microspheres for covalent immobilization of semi-conductor nanoparticles.
- This example relates to, but is not limited to, the covalent coupling of functionalized, or pre-activated, microspheres to functionalized, or pre-activated nanospheres using a linker or bridge between the two particles.
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, microspheres for covalent immobilization of dendrimers.
- This example relates to, but is not limited to, the covalent coupling of biomolecules to microspheres via a novel linker.
- This example relates to, but is not limited to, the covalent labeling of a biomolecule with a functionalized, or pre-activated fluorophore.
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, biomolecules for the covalent immobilization onto a solid surface.
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, particles for the covalent immobilization of fluorophores.
- aspects of the invention include materials and procedures for preparing compositions, conjugates and/or mixtures involving polymer particles, various linkers and functional groups. These linkers and functional groups are described as follows: (7.0) synthetic procedures of surface functional groups and spacers, (7.1) evaluation of novel reactive groups, (7.2) examples of coupling procedures. Such descriptions provided herein are not intended to limit the present invention in any way.
- the following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention.
- the following example describes a method for activating carboxylated polystyrene microspheres with sulfonyl chloride groups.
- microspheres were washed two times with 250 ⁇ L of benzene and dried under reduced pressure ( ⁇ 5 torr) for 2 hours. They were suspended in a solution of potassium 7-amino-1,3-disulfonylnaphthalene in 200 ⁇ L of pyridine and kept at room temperature for 4 hours.
- the following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention.
- the following example describes a method for activating carboxylated polystyrene microspheres with sulfonyl fluoride groups.
- the following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention.
- the following example describes a method for activating carboxylated polystyrene microspheres with mono-fluoro squaric acid groups using adipic acid dihydrazide as a linker.
- microspheres were washed three times with 500 ⁇ L of water, three times with 500 ⁇ L of methanol, and three times with 500 ⁇ L of benzene. The microspheres were then suspended in 500 ⁇ L of benzene and 14, of dibutoxy cyclobutene dione was added. After shaking on a thermal shaker for 14 hours at 25° C., the microspheres were washed three times with 500 ⁇ L of benzene, three times with 500 ⁇ L of methanol, and three times with 500 ⁇ L of DI water. To the microspheres was added 500 ⁇ L of a 1M solution of sodium hydroxide. The microspheres were then placed in a thermal shaker for 2 hours at 60° C.
- the following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention.
- the following example describes a method for activating carboxylated polystyrene microspheres with cyanuric fluoride using 1,6-diaminohexane as a linker.
- microspheres were washed three times with 500 ⁇ L of water, three times with 500 ⁇ L of methanol, and three times with 500 ⁇ L of acetonitrile.
- the microspheres were then suspended in a solution containing 500 ⁇ l, of acetonitrile, 20 ⁇ L of trimethyl amine and 15 ⁇ L of cyanuric fluoride and was set for 14 hours at ⁇ 15° C. Finally they were washed three times with acetonitrile.
- the microspheres were suspended and stored in 1 mL of acetonitrile. The just described procedure is graphically described in Entry 4 of Table 1.
- the following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention.
- the following example describes a method for activating carboxylated polystyrene microspheres with vinyl sulfone (VS) using 2-aminoethanethiol as a linker.
- VS vinyl sulfone
- the microspheres were washed three times with 500 ⁇ L of water and three times with 500 ⁇ L of 0.1M sodium chloride/0.1M sodium acetate buffer, pH 4.5.
- the disulfide bonds of the bound cysteamine groups were reduced by suspending the microspheres in 500 ⁇ L of a 11 mg/mL solution of dithiothreitol (DTT) in 0.1M sodium acetate/0.1M sodium chloride buffer, pH 4.5.
- DTT dithiothreitol
- the microspheres were placed on a rotating mixer for 30 minutes and afterwards washed three times with 500 ⁇ l, of methanol. Then they were suspended in 500 ⁇ L of dichloromethane and 5 ⁇ L of vinyl sulfone (VS) was added.
- the following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention.
- the following example describes a method for converting the activated polystyrene microspheres of the previous example into a more hydrolysis resistant form.
- Microspheres prepared according to Example 5.0.5 were suspended in 800 ⁇ L of a solution containing 3 mg of sodium thiosulfite, 0.01% Tween 20, and sodium phosphate buffer, pH 4.0 for 14 hours. The microspheres were washed three times with 500 ⁇ L of DI water. The microspheres were suspended and stored in 1 mL of DI water. The microspheres are not reactive with nucleophiles unless they are first treated with a buffer of pH 9-10. The just described procedure is graphically described in Entry 5c of Table 1.
- the following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention.
- the following example describes a method for directly activating carboxylated polystyrene microspheres with tetra-fluoro sulfophenyl esters.
- biotin-LC-PEO-amine obtained from Pierce, Rockford, Ill.
- streptavidin-PE obtained from Molecular Probes, Eugene, Oreg.
- the modified microspheres are evaluated by reacting the biotin-amine directly, followed by reaction with streptavidin-PE. Functional group stability was evaluated by storing the microspheres either in buffer (pH 6; 4° C.) or dry, and performing the biotin-LC-PEO-amine assay at set intervals (e.g., days, weeks, months, etc.).
- novel reactive groups exhibit very desirable properties.
- novel reactive groups show good reactivity with nucleophilic compounds, have substantially improved stability in aqueous media, form stable conjugates, require no additional activating reagents (e.g., EDC and/or NHS esters), and may provide more specific conjugation (i.e., reduce non-specific interaction/binding with solid substrates) thus protecting the integrity of biomolecules.
- the mono-fluoro squaric acid (MFS)-modified microspheres lost some activity gradually, retaining 80% activity at the end of the study (i.e., the greatest change in activity was shown at the end of 350 equivalent days). Improvements in storage procedures are expected to eliminate any loss of activity for modified microspheres.
- FIG. 2 depicts an example of the stability of vinyl-sulfone (VS)-functionalized microspheres in buffer for at least 30 days. This is a substantial improvement compared to EDC and NHS reagents, however, since there is a trade-off between reactivity and stability, we have also evaluated various drying and storage methods for long-term storage (including for example, 6 months, ⁇ approximately 6 months, greater than six months, six months to nine months, six months to one year, six months to two years, etc.) of the modified microspheres.
- FIGS. 3-6 depict examples of dry storage condition stability studies. Storage vessels that provide superior moisture barrier properties to those used in this study, will prevent loss of activity over time.
- FIG. 7 shows a coupling titration of an amino-modified DNA probe on COOH-functionalized microspheres (EDC-mediated reaction) vs. pre-activated microsphere method. Both coupling titrations were performed at 25° C. The DNA compliment target concentration for the assay was 20 fmoles at a hybridization temperature of 55° C. Results show the COOH-EDC method yields a non-linear response to the amount of probe coupled to the microsphere. The pre-activated microsphere probe titration is more linear, suggesting a more specific coupling of the probe. Both results are reproducible. Note: 25° C. is not an optimal coupling temperature for the pre-activated microspheres. The signal is expected to improve with optimization of coupling temperature, as well as other parameters.
- microspheres were washed three times with phosphate buffer (pH 6, 100 mM) and counted. 2.5 ⁇ 10 7 microspheres were aliquoted and washed once with phosphate buffer (pH 8, 100 mM).
- a solution of PEO-LC-biotin-amine (17.4 mg/mL) was prepared in phosphate buffer (pH 8, 100 mM). 100 ⁇ L of this solution was added to the microspheres, in 900 ⁇ L phosphate buffer (pH 8, 100 mM). The suspension was incubated at 37° C. for 1 hour.
- microspheres were washed three times with PBS-TBN (phosphate buffered saline, pH 7.4 with 0.02% Tween 20 and 1 g/L bovine serum albumin), and recounted.
- PBS-TBN phosphate buffered saline, pH 7.4 with 0.02% Tween 20 and 1 g/L bovine serum albumin
- a suspension of 100,000 microspheres/mL PBS-TBN was reacted with 1 ⁇ g Streptavidin-PE for 1 hour at room temperature.
- the microspheres were washed three times and resuspended in 1 mL PBS-TBN.
- the fluorescence intensity of the microspheres was analyzed on a Luminex 100TM instrument.
- a suspension of 25 ⁇ 10 6 surface-modified microspheres was washed with 1 mL carbonate buffer (pH 9, 100 mM).
- a 1 mL solution of IgG 50 ⁇ g/mL in 0.1M pH 9 carbonate buffer
- was added to the microspheres vortexed, sonicated and incubated at 37° C. for 1 hour.
- the sample was washed with 1 mL PBS-TBN (phosphate buffered saline, pH 7.4 with 0.02% Tween 20 and 1 g/L bovine serum albumin).
- a suspension of 100,000 microspheres/mL PBS-TBN was reacted with 1 ⁇ g Streptavidin-PE for 1 hour at room temperature. Subsequently the microspheres were washed three times and resuspended in 1 mL PBS-TBN.
- the fluorescence intensity of the microspheres was analyzed on a Luminex 100TM instrument.
Abstract
Description
- The present application is a divisional from U.S. application Ser. No. 11/621,209 filed Jan. 9, 2007 which is a divisional from U.S. application Ser. No. 10/293,260 filed Nov. 14, 2002 which claims priority to U.S. Provisional Application No. 60/331,312 filed Nov. 14, 2001, all of which are incorporated herein by reference.
- The present invention relates to improved covalent coupling of two or more entities such as biomolecules, polymer compositions, organic/inorganic molecules/materials, and the like, including their combinations, through one or more novel reactive groups attached to linker groups of 2-1000 atoms length.
- The immobilization of entities (such as enzymes, antibodies, proteins, DNA, nucleotides, PNA, carbohydrates, fatty acids, lectins, peptides, receptors, chromophores, fluorophores, chemiluminescent compounds, dendrimers, J or H aggregates, cells, bacteria, viruses, whole prokaryotic or eukaryotic organisms, membranes (synthetic or natural), fullerenes, nanotubes and the like) can be achieved by simple covalent reaction with an activated solid surface. For example, particles (e.g., micro- and nano-spheres; metal particles comprised of one or more metals with any size, shape, or composition; semiconductor particles, molecularly imprinted polymers (MIPS), magnetic particles; or dyed materials) or microtiter plates are a common solid matrix in many immobilization systems. Preparing and maintaining the active, functionalized surface is an important factor to assure immobilization of sufficient biological material for development of a sensitive assay. Current immobilization procedures of biomolecules on solid surfaces generally involve reactions of an activated amino or carboxyl group derivatized solid surface with amino- or thiol-modified biomolecules. After activation, or after introduction of a functionalized spacer, these groups offer direct attachment sites. Most of these functional groups (such as NHS esters, isothiocyanates, etc.) are prone to hydrolysis in an aqueous environment and become non-reactive (i.e., chemically inactive) in a matter of less than an hour.
- Reactive or functionalized microspheres are conventionally produced via copolymerization of suitably functionalized monomers, or via post-chemical modification of preformed microspheres. Post-functionalization is a popular method for preparing reactive particles as earlier described by Upson (J. Polym. Sci., Polym. Symp. 1985, 72, 45).
- In the last three decades the advancements in the field of affinity chromatography, solid-phase synthesis, and immobilization of bio-macromolecules, such as proteins, oligonucleotides and the like, have led to microsphere-based biomedical applications. More recent work on the production and evaluation of a variety of tailor-made particles has been reported by several groups including Margel et al., (J. Polym. Sci. 1991, A-29, 347-355; Anal. Biochem. 1981, 128, 342-350), Ugelstad et al., (Makromol. Chem. 1979, 180, 737-44; Adv. Colloid Interface Sci. 1980, 13, 102-140), and Rembaum et al. (Br. Polym. J. 1978, 10, 275-280; J. Macromol. Sci. Chem. 1979, A-13, 603-632). A review by R. Arshady, (Biomaterials, 1993, 14, 5-15) describes the synthesis and physicochemical properties of reactive and labeled microspheres.
- Assays based on fluorescent microspheres for multiplexed analysis have been reported by several groups (Fulton et al., Clin. Chem. 1997, 43, 1749-56; Kettman et al., Cytometry, 1998, 33, 234-43; McDade et al., Med. Dev. Diag. Indust. 1997, 19(4), 75-82; McHugh, Methods Cell Biol. 1994, 42, 575-95; Nikiforov et al., Nucleic Acid Res. 11994, 22, 4167-75; U.S. Pat. No. 6,449,562; U.S. Pat. No. 5,981,180; U.S. Pat. No. 6,046,807; U.S. Pat. No. 6,057,107; U.S. Pat. No. 6,268,222; U.S. Pat. No. 6,366,354; U.S. Pat. No. 6,411,904; U.S. Pat. No. 5,736,330; U.S. Pat. No. 6,139,800).
- Fray et al. have reported a strategy in which particles are pre-activated with hydrolysis-resistant aldehyde functional groups but low reaction yields of <8% have been observed with these microspheres (Bioconjugate Chem. 1999, 10, 562-71). Milton of Beckman Coulter, Inc.
- has reported a reaction between an acyl fluoride activated polymer-surface and an amino derivatized biomolecule at room temperature (U.S. Pat. No. 6,146,833; Nov. 14, 2000). The use of fluorophenyl resins in the solid phase synthesis of amides, peptides, hydroxamic acids, amines, urethanes, carbonates, sulfonamides and alpha-substituted carbonyl compounds has been published (WO 99/67228).
- Medvedkin et al. have used sulfo-tetrafluorophenyl activated esters in peptide synthesis and demonstrated their reactivity combined with good stability under aqueous storage conditions (Bioorg. Khim. 1995, 21(9), 684-90). Apparently, the pre-activation of polystyrene surfaces with this reagent has not yet been reported prior to the present application.
- Hoechst claimed the use of reactive vinyl sulfone (VS)-modified dyes for dyeing of cellulose and wool fibers in 1950 (DBP 960,534). A review by Siegel gives a complete account of reactive dyes based on vinyl sulfones (VS) and its protected 2-sulfatoethyl and 2-thiosulfatoethyl sulfones (E. Siegel in The Chemistry of Synthetic Dyes Vol. VI, (Ed. K Venkataraman); 2-108, Academic Press, 1972). Sterling Winthrop Inc, has demonstrated modification of proteins with PEG-supported vinyl sulfone (U.S. Pat. No. 5,414,135).
- The most frequently used method to immobilize biomolecules (such as oligonucleotides, proteins, or carbohydrates) onto fluorescent microspheres is by activating surface carboxy groups. The activation requires excess EDC and a coupling pH of 4 to 6. The reaction involves the intermediate formation of an activated O-acylurea derivative between the carbodiimide and carboxyl functions. A subsequent nucleophilic attack by the primary nitrogen of the amino-groups of the biomolecule brings about the formation of the amide linkage with the release of the substituted urea. The optimum pH for the formation of O-acylurea is about pH 4-5. The intermediate has an extremely short half-life and rapidly undergoes hydrolysis or rearranges to give the N-acylurea adduct. The primary amino group of the nucleophile is predominantly protonated at about pH 4-5 and is thus mostly unreactive. These limitations can severely restrict coupling yields. At low pH, the nucleic acid bases undergo intensive protonation. Such type of protonation induces a DNA melting that exposes the hydrophobic core of the helix, enhancing nonspecific hydrophobic interactions with the solid matrix. Despite these drawbacks, EDC-mediated coupling currently is the major mode of covalent immobilization of biomolecules to solid surfaces (Hermanson, G. T. in Bioconjugate Techniques, Academic Press; N.Y. 1996; Andreas Frey et. al., Bioconjugate Chem. 1999, 10, 562-71; Maxime A. Gilles et. al., Anal. Biochem., 1990, 184, 244-48; Vivien W. F. Chan et. al., Biochem. Biophys. Res. Communications., 1988, 151(2), 709-16; Ivan L. Valuev et al., Biomaterials, 1998, 19, 41-43).
- The citations of the various references described above and throughout this application are not to be taken as admissions that these references constitute prior art for the present invention. However, each of the cited references is incorporated in its entirety by reference in the present application.
- The present invention is based, at least in part, upon improved methods and compositions for covalent coupling of two or more entities (B, B′, etc.) such as biomolecules, polymer compositions, organic and/or inorganic molecules and/or materials, etc., through one or more “novel reactive groups” (Structures 1-6). The illustrations and examples provided herein are not intended to limit the scope of the invention in any way.
- Entities B, B′, etc., under the present invention comprise, but are not limited to, glass, quartz, monomer, polymer, dendrimer, MIPS, membranes, metal, clay, diatomaceous earth, particle (dyed or undyed), particle (magnetic or non-magnetic), particle (micro- or nanospheres), fullerenes, nanotubes, biomolecule, chromophore, fluorophore, chemiluminescent compound, semiconductor particles, semiconductor nanocrystals (quantum dots), J- or H-aggregates, cells, organisms, bacteria, viruses, or any combination thereof. Entities B, B′, etc., can be the same or different, and can be functionalized or non-functionalized.
- The novel reactive groups of the present invention are conjugated to entities B, B′, etc., by way of a linker, (L)n, where L is a hydrocarbon linker with n number of atoms (e.g., 2 to 1000) of H, C, O, N, Si, P and S in straight or branched chains, rings, or combinations thereof.
- In some embodiments, one or more entities B, B′, etc., are nucleophile-containing entities, i.e., they contain hydroxyl, amine, thiol, etc., groups, or the entities are conjugated to such groups. In such cases, attachment of the novel reactive groups may be accomplished by the chemical reaction of the electrophilic reactive group of one or more of Structures 1-6 with the nucleophilic group contained on or within the entity. Such chemical reactions include, but are not limited to, nucleophilic addition or nucleophilic-based reaction known to a person of ordinary skill in the art, substitution and/or displacement.
- By way of a non-limiting example, a reaction of the present invention whereby two entities, B and B′, are cross-linked via one or more of Structures 1-6. Any nucleophile- or electrophile-containing groups are termed A, A′, etc., where A and/or A′ are a novel reactive group, or combination thereof, discussed in the present invention and/or a nucleophile (e.g., alcohol, amine, thiol, etc.), respectively. A and A′ can be the same or different novel reactive group and/or the same or different nucleophile. B and B′ can either be the same and/or different entities. Several possible combinations of such elements are discussed, below.
- In one embodiment, one entity B, a polymeric microsphere, is conjugated with an electrophile-containing group of one of Structures 1-6 through the group's respective linker R1-R6. A second entity, B′, a semiconductor nanoparticle, is conjugated with a nucleophilic group at its surface. A straightforward nucleophilic substitution reaction results in the linking of B with B′ by way of the linker.
- In yet another embodiment of a reaction linking B and B′, where A and A′ are both novel reactive groups of Structures 1-6, or a combination thereof, a bifunctional linker or bridge molecule is used to covalently couple the two or more entities. In one such embodiment, the bifunctionality of the linker is nucleophilic (e.g., amine, thiol, etc.). In other words, the bridge molecule contains two or more nucleophilic groups, one of which reacts with each of A and A′ such that B and B′ are linked through the combined length of the linker arms of A and A′ and the length of the bridge molecule.
- In yet another embodiment, B and B′ contain A and A′, respectively, which are both nucleophiles. In this embodiment, a bifunctional linker or bridge molecule is used to couple the two or more entities whereby the bifunctionality of the linker or bridge molecule are one or more novel electrophilic reactive groups of Structures 1-6, where those groups can be the same or different novel reactive groups. The bridge molecule may or may not be constructed by joining the free ends of the linkers R1-R6 of the respective electrophilic reactive groups of Structures 1-6. Following the reaction of these elements, B and B′ are linked via the bifunctional bridge molecule binding covalently to their respective nucleophilic groups. In another version of this embodiment, if A and A′ are both nucleophiles, then a bifunctional linker or bridge molecule is used to couple the two or more entities wherein C and/or C′ are a functional group or groups (e.g., NHS ester, isothiocyanate, sulfonyl chloride, etc.) known to react with nucleophiles A and A′. C and C′ can be the same or different functional groups which are attached to the linker or bridge molecule by way of one or more (n) novel electrophilic reactive groups of Structures 1-6 where n is the number of novel electrophilic reactive groups.
- In particular, the present invention is directed toward novel conjugated compositions comprising one or more, in any combination, of Structures 1-6:
- wherein:
-
- n is 0, 1, 2, or 3;
- X and Y are oxygen and/or sulfur in any combination;
- X2 and X3 are one or more halogens, preferably chlorine or fluorine;
- Y2 is nitrogen or carbon; arom is a substituted or unsubstituted phenyl, naphthyl or other polycyclic aromatic ring structure;
- Z is a halide, preferably chloride or fluoride, 2,3,5,6-tetrafluoro-4-sulfo-phenoxide, N-hydroxysuccinimide or other electrophilic (nucleofugal) group; and
- R1-R6 are hydrocarbon linker groups containing from 2-1000 atoms, optionally containing one or more halogen or heteroatoms selected from the group consisting of O, N, Si, P and S; in straight or branched chains, rings, or combinations thereof; and
wherein the one or more, in any combination, of Structures 1-6 are connected through their respective linker groups, R1-R6, to at least one entity B, wherein B is: - a 2-D film or substrate;
- a micro- or nano-particle of any size or shape composed of organic polymer, MIPS, glass, metal, clay, resin, diatomaceous earth, zeolite, inorganic crystal, semiconductor particle, semiconductor nanocrystal, magnetic particle, fullerene, nanotube, or any combination thereof;
- an enzyme, antibody, protein, DNA, RNA, nucleotide, PNA, carbohydrate, fatty acid, lectin, peptide, receptor, dendrimer, cell, bacteria, virus, whole prokaryotic or eukaryotic organism, synthetic or natural membrane, biotin, hapten, organic monomer or polymer, or any combination thereof;
- a chromophore, fluorophore, bio- or chemi-luminescent compound, J or H aggregate; one or more of Structures 1-6 connected through their respective linker groups R1-R6; or any combination thereof.
- In yet another further embodiment, the present invention is directed to novel compositions as described above wherein R1-R6 contain 2-100 atoms, or more preferably wherein R1-R6 contain 2-10 atoms.
- The present invention also encompasses compositions comprising the Structures 1-6 noted above, wherein R1-R6 comprise hydrocarbon linker groups containing, optionally, one or more halogen or heteroatoms selected from the group consisting of O, N, Si, P and S; in straight or branched chains, rings, or combinations thereof containing from 2-1000 atoms, preferably 2-100 atoms, or more preferably wherein R1-R6 contain 2-10 atoms.
- The present invention also is directed toward compositions as described above wherein B is a polymeric microsphere or nanosphere. Even more preferred is an embodiment wherein the polymeric microsphere further comprises polystyrene/divinyl benzene and/or carboxyl functional groups at least on its surface, and even more preferred is an embodiment wherein the microsphere further comprises one or more fluorescent dyes in distinguishable ratios.
- As noted above, the present invention relates, in a preferred embodiment, to functionalized microspheres. A series of reactive functional groups has been evaluated on polystyrene-based microspheres for their ability to immobilize biomolecules, which biomolecules comprise prokaryotic or eukaryotic cells, transgenic cells, organisms, bacteria, viruses, plasmids, expression vectors, enzymes, proteins, fusion proteins, antibodies, chimeric antibodies, DNA, RNA, PNA, fatty acids, lectins, peptides, and receptors, or any combination thereof. Activated oxocarbon acids (e.g., mono-fluoro squaric acid (MFS)), tetra-fluoro-sulfophenyl ester (TFS), vinyl sulfone (VS), dihaloquinoxaline, sulfonyl fluoride, cyanuric acid halide and halopyrimidine show improved performance for immobilizing biomolecules as they (a) spontaneously react with nucleophilic groups of biomolecules, (b) show substantially improved stability in aqueous media, (c) form stable conjugates with biomolecules, (d) require no additional activating reagents and (e) may provide more specific conjugation (i.e., reduced nonspecific interaction/binding with solid substrates) thus protecting the integrity of the biomolecule.
- In yet another embodiment, a novel reactive group can be attached first to a biomolecule and then coupled to a solid support containing nucleophilic groups. Also disclosed are new linker systems aimed at improving the coupling yields of biomolecules to solid surfaces.
- In particular, the present invention is directed toward a method for coupling two or more entities together by providing one or more conjugate compositions as described above having one or more, in any combination, of Structures 1-6 connected through their respective linker groups, R1-R6, to at least one entity B; providing one or more nucleophile-containing entities comprised of:
-
- a 2-D film or substrate;
- a micro- or nano-particle of any size or shape, composed of organic polymer, MIPS, glass, metal, clay, resin, diatomaceous earth, zeolite, inorganic crystal (including semiconductors, semiconductor nanocrystals, and magnetic particles), fullerene, nanotube or any combination thereof;
- an enzyme, antibody, protein, DNA, RNA, nucleotide, PNA, carbohydrate, fatty acid, lectin, peptide, receptor, chromophore, fluorophore, bio- or chemi-luminescent compound, J or H aggregate, cell, bacteria, virus, whole prokaryotic or eukaryotic organism, synthetic or natural membrane, biotin, hapten, organic monomer or polymer, or dendrimer, or any combination thereof; and
reacting the one or more conjugate compositions with the one or more nucleophile containing entities to produce at least one entity B linked through one or more linker arms of Structures 1-6 to said one or more nucleophile-containing entities.
- In another embodiment, the present invention encompasses a method for the synthesis of compositions noted above wherein the one or more, in any combination, of Structures 1-6 are conjugated to the entity B before the fabrication of the entity B; during the fabrication of the entity B; or after the fabrication of entity B.
- Another preferred embodiment of the present invention is directed toward a method of crosslinking one or more nucleophile-containing entities comprising reacting a composition of Structure 1, as described above, wherein:
-
- (a) n is 0, 1, 2, or 3;
- (b) X and Y are oxygen and/or sulfur in any combination;
- (c) Z and R1 are halogen (including chloride and fluoride); 2,3,5,6-tetrafluoro-4-sulfo-phenoxide; N-hydroxysuccinimide; and similar nucleofugal groups or any combination thereof;
- with one or more nucleophile-containing entities, comprised of:
- a 2-D film or substrate;
- a micro- or nano-particle of any size or shape, composed of organic polymer, MIPS, glass, metal, clay, resin, diatomaceous earth, zeolite, inorganic crystal (including semiconductors, semiconductor nanocrystals, and magnetic particles), fullerene, nanotube or any combination thereof;
- an enzyme, antibody, protein, DNA, RNA, nucleotide, PNA, carbohydrate, fatty acid, lectin, peptide, receptor, chromophore, fluorophore, bio- or chemi-luminescent compound, J or H aggregate, cell, bacteria, virus, whole prokaryotic or eukaryotic organism, synthetic or natural membrane, biotin, hapten, organic monomer or polymer, or dendrimer or any combination thereof;
- to provide one or more crosslinked nucleophile-containing entities.
- In yet an even further embodiment, the present invention is directed toward the use of Structures 1-6 in the creation of bridge molecules for linking two or more entities together, or compositions comprising one or more of Structures 1-6 as bridge molecules. Various embodiments of the present invention include multifunctional bridge molecules of two or more of Structures 1-6 joined through their respective linker groups R1-R6, in an end-to-end fashion, in a branched chain, or in dendritic fashion. Such bridge molecules may be used to link together covalently two or more entities having nucleophilic groups by straightforward chemical reactions such as nucleophilic addition or substitution or any other applicable chemical reaction known to a person of ordinary skill in the art.
- In yet another variation of this invention, a multifunctional bridge molecule is provided wherein the functional groups are one of more of Structures 1-6 and one or more nucleophilic groups. Such bridge molecules may be used to link together covalently one or more entities having nucleophilic groups with one or more entities conjugated to one or more of Structures 1-6 by straightforward chemical reactions such as nucleophilic addition or substitution, wherein the entity(ies) having nucleophilic groups react with the bridge group, functionality(ies) of Structures 1-6, and the entity(ies) having reactive groups of Structures 1-6 react with the nucleophilic bridge group functionality(ies) to yield two or more entities linked together.
- Compositions of such multifunctional bridge groups are also envisioned. A bridge group composition is envisioned wherein one or more of Structures 1-6, in any combination, are conjugated by their respective linker groups R1-R6 to one or more nucleophilic groups, wherein if two or more of Structure 1-6 are joined together, they are joined together through their respective linker groups R1-R6, wherein the joining is one or more of end-to-end, branched, or dendritic, in any combination.
-
FIG. 1 shows a comparison of the COOH-functionalized microsphere, EDC coupling method (A) to mono-fluoro squaric acid-functionalized microspheres (MFS) (B) over time (accelerated at 25° C.). The novel pre-activated microspheres (B) provide more reproducible coupling day-to-day than the standard EDC-mediated reactions (A). -
FIG. 2 shows a stability study of vinyl sulfone (VS)-functionalized microspheres stored in buffer, pH 6 at 4° C. -
FIG. 3 shows an accelerated stability study of mono-fluoro squaric acid (MFS)-functionalized microspheres stored dry. -
FIG. 4 shows an accelerated stability study of mono-fluoro squaric acid (MFS)-functionalized microspheres stored dry over a longer time period than shown inFIG. 3 . -
FIG. 5 shows an accelerated stability study of tetra-fluoro-sulfophenyl ester (TFS)-functionalized microspheres stored dry. -
FIG. 6 shows an accelerated stability study of vinyl sulfone (VS)-functionalized microspheres stored dry. -
FIG. 7 shows a coupling titration of an amino-functionalized DNA probe on (A) COOH-functionalized microspheres (EDC-mediated reaction) vs. (B) mono-fluoro squaric acid (MFS)-functionalized microspheres (spontaneous reaction) methods. Both coupling titrations were performed at 25° C. The DNA compliment target concentration for the assay was 20 fmoles at a hybridization temperature of 55° C. The COOH-EDC method (A) yields a non-linear response to the amount of probe coupled to the microspheres. The mono-fluoro squaric acid-functionalized microsphere's probe titration (B) is more linear. These results are reproducible and may be the result of a more specific coupling. Note: 25° C. is not an optimal coupling temperature for the mono-fluoro squaric acid-functionalized microspheres. Signal is expected to improve with optimization of all parameters. - 6.1 Functional Groups
- Because of the shortcomings of current coupling methods—lack of stability or inability to spontaneously react with biomolecules in aqueous media or both—the inventors decided to introduce hydrolysis-resistant, ready to use, pre-activated microspheres, for the immobilization of biomolecules. Table 1 is a partial, non-limiting, list of such novel reactive microspheres.
- Sulfonyl fluorides are known to be more stable in an aqueous environment than sulfonyl chlorides (Table 1, 1a-1d) and the aromatic versions are more stable as compared to their aliphatic counter parts. Several routes starting either from acids or acid chlorides were used to synthesize sulfonyl fluorides (Table 1, 2a-2e) on the surface of polystyrene microspheres.
- The cyclic oxo-carbon acids (deltic, squaric, croconic and rhodizonic) have two acid equivalents and 1-4 carbonyl groups in a ring. The inventors have used one of the acid equivalents to connect the ring to one of our linker molecules and activated the other to a reactive derivative. Several routes to synthesize squaric acid derivatized microspheres are provided in Table 1 (3a-3e). The resulting activated beads are very reactive with amine containing molecules and can be stored on a long term basis if kept dry. This class of reactive group can also be used as a replacement for NHS esters and the like to activate dyes and biomolecules.
- Cyanuric fluoride can react with up to three equivalents of amine, replacing the fluorine atoms with the nitrogen atoms of the amines. The inventors have isolated microspheres in which cyanuric fluoride was reacted with one equivalent of an amine linker, which was attached to a microsphere (Table 1, 4). The second and third fluorine are still available for reaction with bio-molecules. Related molecules such as cyanuric chloride, 2,4,6-trichloro pyrimidine or 2,4,6-trifluoropyrimidine are used similarly.
- Vinyl sulfone (VS) microspheres were generated by reacting divinyl sulfone with microspheres containing hydroxy, amino or thiol groups (Table 1, 5a-5b). The remaining vinyl moiety is available for reaction with both thiols and amines. This group is less susceptible to hydrolysis, but requires a basic pH for reaction with amines. The vinyl sulfone (VS) group can be protected from oxidation during long term storage by reacting it with sodium thiosulfate as in Table 1, 5c. The vinyl moiety is regenerated at about pH 9-10.
- Perfluorinated phenols have been developed as hydrolysis resistant replacements for N-hydroxysuccinimide for conventional coupling chemistries. The inventors reacted tetrafluoro-phenolsulfonic acid with carboxylic acid groups directly on the surface of microspheres (Table 1, 6) or on the end of a linker molecule. Fluorine atoms provide the moiety with a good leaving group and the sulfonic acid maintains the charge on the surface of the microsphere, which is needed to disperse it in water.
- 6.2. Linkers
- The overall performance of a functionalized microsphere is controlled by several parameters—microsphere charge, density of cross-linking, location, accessibility and chemical stability of functional groups, length, charge and nature of the linker group.
- Linkers play an important role in bioconjugations. They are selected based not only on their length, but their chemical nature. The overall nature of the linker is known to govern the overall hydrophilicity or hydrophobicity of the reagent environment. It is well understood that extended linkers can reduce the steric interferences between the analyte and the solid matrix.
- Several different classes of linkers could be used to connect the above mentioned functional groups to microspheres. Examples of these linkers are shown in Table 2.
- Ethylene glycol based linkers (Table 2, 1-3) are surface modifiers which are known for improving the stability of hydrophilic surfaces. Additional stability is ensured by replacing CH2 with CF2. Straight chain polymethylenes (Table 2, 4) are other linkers that may be used to connect the above mentioned functional groups to microspheres.
- Diamines and hydrazides are known to provide hydrophobic surfaces (Table 2, 5-8). Polyethylenimines (Table 2, 9) exhibit a ‘proton sponge’ effect, which can be used to control the surface charge of the microsphere. Polyamides and polysulfonamides (Table 2, 10-13) contain acidic protons with a pKa of about 1-2. These linkers, therefore, provide polyanions at physiological pH and hence provide long storage stability. Dendrimers or highly branched linkers (Table 2, 14) are known to adopt to well defined morphologies and provide a kind of encapsulation to the reactive groups and hence protect them from hydrolysis. DTPA (diethylene triamine pentaacetic acid) linkers (Table 2, 1S) provide multiple carboxylates. These type of linkers are known to form stable metal complexes. Polyacrylic acid and polylysine chains (Table 2, 16-17) can be introduced to improve the degree of immobilization.
- 6.3. Examples of Specific Application
- The following are examples of specific applications of the present invention. These examples are not intended to limit the scope of the invention in any way.
- 6.3.1 Example
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, microspheres for covalent immobilization of biomolecules.
-
- (a) A solid support comprised of a polymeric microsphere, preferably polystyrene/divinyl-benzene, containing carboxyl functional groups at least on its surface.
- (b) The solid support (a) where the solid support contains one or more fluorescent dyes in distinguishable ratios.
- (c) Solid support (b) where at least surface carboxyl groups have been modified with a 4,7,10-trioxa-1,13-tridecanediamine linker.
- (d) Solid support (c) where the linker has been modified and/or contains the novel reactive group mono-fluoro squaric acid (MFS).
- (e) A biomolecule, specifically an oligonucleotide probe, containing a primary amine terminus.
- (f) Spontaneous, covalent coupling of solid support (d) and biomolecule (e) to form a stable, covalent bond.
- (g) Use of the biomolecule-coupled solid support (f) in a single or multiplexed DNA assay.
- 6.3.2 Example
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, microspheres for covalent immobilization of biomolecules.
-
- (a) A solid support comprised of a polymeric microsphere, preferably polystyrene/divinyl-benzene, containing carboxyl functional groups at least on its surface.
- (b) The solid support (a) where the solid support contains one or more fluorescent dyes in distinguishable ratios.
- (c) Solid support (b) where at least surface carboxyl groups have been modified with a cystamine linker.
- (d) Solid support (c) where the linker has been modified and/or contains the novel vinyl sulfone (VS) reactive group.
- (e) A biomolecule, specifically an antibody, containing a primary amine or thiol.
- (f) Spontaneous, covalent coupling of solid support (d) and biomolecule (e) to form a stable, covalent bond.
- (g) Use of the biomolecule-coupled solid support (f) in a single or multiplexed immunoassay.
- 6.3.3 Example
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, microspheres for covalent immobilization of biomolecules.
-
- (a) A solid support comprised of a polymeric microsphere, preferably polystyrene/divinyl-benzene, containing carboxyl functional groups at least on its surface.
- (b) The solid support (a) where the solid support contains one or more fluorescent dyes in distinguishable ratios.
- (c) Solid support (b) where the carboxyl groups have been modified to contain the novel tetra-fluoro-sulfophenyl ester (TFS) reactive group.
- (d) A biomolecule, specifically an antigen, containing a primary amine.
- (e) Spontaneous, covalent coupling of solid support (c) and biomolecule (d) to form a stable, covalent bond.
- (f) Use of the biomolecule-coupled solid support (e) in a single or multiplexed immunoassay.
- 6.3.4 Example
- This example relates to, but is not limited to, the use of a solid surface for covalent immobilization of functionalized, or pre-activated biomolecules.
-
- (a) A two-dimensional solid support comprised of quartz, and containing hydroxyl functional groups at least on its surface.
- (b) Solid support (a) where at least surface hydroxyl groups have been modified with aminopropyl-triethoxy silane, an amino-terminated silane linker.
- (c) A biomolecule, specifically an oligonucleotide, where the terminus has been modified to contain the novel reactive group mono-fluoro squaric acid (MFS).
- (d) Spontaneous, covalent coupling of solid support (b) and biomolecule (c) to form a stable, covalent bond.
- (e) Use of the biomolecule-coupled solid support (d) in a single or multiplexed DNA assay.
- 6.3.5 Example
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, microspheres for covalent immobilization of semi-conductor nanoparticles.
-
- (a) A solid support comprised of a polymeric microsphere, preferably polystyrene/divinyl-benzene, containing carboxyl functional groups at least on its surface.
- (b) Solid support (a) where the carboxyl groups have been modified to contain the novel vinyl sulfone (VS) reactive group.
- (c) One or more semi-conductor nanoparticles having one or more distinguishable fluorescence emissions or wavelengths.
- (d) Semi-conductor nanoparticles (c) having at least thiol functional groups at least on the surface of the particles.
- (e) Spontaneous, covalent coupling of solid support (b) and semi-conductor nanoparticles (d) to form a stable, covalent bond.
- (f) Use of the semi-conductor nanoparticles-coupled solid support (e) for decoding in a single multiplexed assay.
- 6.3.6 Example
- This example relates to, but is not limited to, the covalent coupling of functionalized, or pre-activated, microspheres to functionalized, or pre-activated nanospheres using a linker or bridge between the two particles.
-
- (a) A solid support comprised of a polymeric microsphere, preferably polystyrene/divinyl-benzene, containing carboxyl functional groups at least on its surface.
- (b) Solid support (a) where the carboxyl groups have been modified to contain the novel mono-fluoro squaric acid (MFS) reactive group.
- (c) Solid support (b) where the novel mono-fluoro squaric acid (MFS) reactive group has been modified with the bifunctional linker 4,7,10-trioxa-1,13-tridecanediamine.
- (d) A second solid support comprised of polymeric nanospheres, preferably polystyrene/divinyl-benzene, containing carboxyl functional groups at least on its surface.
- (e) Solid support (d) where the carboxyl groups have been modified to contain the novel mono-fluoro squaric acid (MFS) reactive group.
- (f) Solid support (e) having one or more fluorescent dyes in distinguishable ratios.
- (g) Spontaneous, covalent coupling of microsphere solid support (c) and nanosphere solid support (f) to form a stable, covalent bond.
- (h) Use of the nanosphere-coupled microsphere solid support (g) for decoding in a single or multiplexed assay.
- 6.3.7 Example
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, microspheres for covalent immobilization of dendrimers.
-
- (a) A solid support comprised of a polymeric microsphere, preferably polystyrene/divinyl-benzene, containing carboxyl functional groups at least on its surface.
- (b) The solid support (a) where the solid support contains one or more fluorescent dyes in distinguishable ratios.
- (c) Solid support (b) where the carboxyl groups have been modified to contain the novel tetra-fluoro-sulfophenyl ester (TFS) reactive group.
- (d) A dendrimer containing primary amine functional groups.
- (e) Spontaneous, covalent coupling of solid support (c) and dendrimer (d) to form a stable, covalent bond.
- (f) Modification of the dendrimer-coupled solid support (e) with a bifunctional linker containing the novel reactive group mono-fluoro squaric acid (MFS) on both termini of the linker.
- (g) A biomolecule, specifically an antibody, containing a primary amine.
- (h) Spontaneous, covalent coupling of solid support (f) and biomolecule (g) to form a stable, covalent bond.
- (i) Use of the biomolecule-coupled solid support (h) in a single or multiplexed immunoassay.
- 6.3.8 Example
- This example relates to, but is not limited to, the covalent coupling of biomolecules to microspheres via a novel linker.
-
- (a) A solid support comprised of a polymeric microsphere, preferably polystyrene/divinyl-benzene, containing carboxyl functional groups at least on its surface.
- (b) The solid support (a) where the solid support contains one or more fluorescent dyes in distinguishable ratios.
- (c) Solid support (b) where at least surface carboxyl groups have been modified with a novel bifunctional amine termini linker containing a least one or more squaric acid functional groups within the linker chain.
- (d) A biomolecule, specifically an oligonucleotide probe, containing the novel tetra-fluoro-sulfophenyl ester (TFS) reactive group at one terminus.
- (e) Spontaneous, covalent coupling of solid support (c) and biomolecule (d) to form a stable, covalent bond.
- (f) Use of the biomolecule-coupled solid support (e) in a nucleic acid-based assay, wherein said assay comprises DNA, RNA, PNA, etc.
- 6.3.9 Example
- This example relates to, but is not limited to, the covalent labeling of a biomolecule with a functionalized, or pre-activated fluorophore.
-
- (a) A fluorophore functionalized, modified and/or synthesized to contain the novel reactive group mono-fluoro squaric acid (MFS).
- (b) A biomolecule, specifically avidin, streptavidin, neutra-avidin and the like containing primary amines.
- (c) Spontaneous, covalent labeling of biomolecule (b) and the pre-activated fluorophore (a) to form a stable, covalent bond.
- (d) A solid support comprised of a polymeric microsphere, preferably polystyrene/divinyl-benzene, containing biotin functional groups at least on its surface.
- (e) The solid support (d) where the solid support contains one or more fluorescent dyes in distinguishable ratios.
- (g) Use of the solid support (e) in a single or multiplexed assay where the fluorophore-labeled biomolecule (c) is used as a reporter molecule.
- 6.3.10 Example
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, biomolecules for the covalent immobilization onto a solid surface.
-
- (a) A solid support comprised of one or more metals.
- (b) The solid support (a) where the solid support has been modified with a self-assembled monolayer (SAM) to contain thiol functional groups.
- (c) A biomolecule, specifically an oligonucleotide, modified and/or synthesized to contain the novel reactive group vinyl sulfone (VS) at one terminus.
- (d) Spontaneous, covalent coupling of solid support (b) and biomolecule (c) to form a stable, covalent bond.
- (e) Use of the biomolecule-coupled solid support (d) in a single or multiplexed nucleic acid-based assay, wherein said assay comprises DNA, RNA, PNA, etc.
- 6.3.11 Example
- This example relates to, but is not limited to, the use of functionalized, or pre-activated, particles for the covalent immobilization of fluorophores.
-
- (a) Solid support particles comprised of one or more metals.
- (b) The solid support (a) where the solid support has been modified to contain the novel functional group mono-fluoro squaric acid (MFS).
- (c) J- or H-aggregate fluorophores containing amines and a quencher molecule.
- (d) Spontaneous, covalent coupling of solid support (b) and fluorophore (c) to form a stable, covalent bond.
- (e) Use of the fluorophore-labeled particles (d) as a reporter in a single or multiplexed assay.
- 7.0 Examples of Synthetic Procedures for Preparing the Novel Reactive Groups
- Aspects of the invention include materials and procedures for preparing compositions, conjugates and/or mixtures involving polymer particles, various linkers and functional groups. These linkers and functional groups are described as follows: (7.0) synthetic procedures of surface functional groups and spacers, (7.1) evaluation of novel reactive groups, (7.2) examples of coupling procedures. Such descriptions provided herein are not intended to limit the present invention in any way.
- 7.0.1 Sulfonyl Chloride
- The following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention. In particular, the following example describes a method for activating carboxylated polystyrene microspheres with sulfonyl chloride groups.
- 100 μL (approximately 11 million microspheres) of a carboxylated polystyrene microsphere solution (5.5 μm) was washed once with 250 μL of DI water, three times with 250 μl, of methanol, and three times with 250 μL of benzene using centrifugation at 13,400×g for 1 minute to pellet and 20 seconds of sonication to resuspend the microspheres. Finally they were suspended in 250 μL, of benzene, 50 μL of thionyl chloride was added and the microspheres were heated at 40° C. for 2 hours. Then the microspheres were washed two times with 250 μL of benzene and dried under reduced pressure (<5 torr) for 2 hours. They were suspended in a solution of potassium 7-amino-1,3-disulfonylnaphthalene in 200 μL of pyridine and kept at room temperature for 4 hours. Then they were washed two times with 250 μL of pyridine, four times with 250 μL of DI water, two times with 250 μL of methanol, and two times with 250 μL of benzene and suspended in a solution of 50 μL thionyl chloride and 25 μL of dimethylformamide (DMF) in 250 μL of benzene and kept at room temperature for 20 minutes and at 40° C. for one hour. Afterwards the reactive microspheres were washed once with 250 μL of benzene and three times with 250 μL of acetonitrile and stored in acetonitrile until used. The just described procedure is graphically described in Entry 1c of Table 1.
- 7.0.2 Sulfonyl Fluoride
- The following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention. In particular, the following example describes a method for activating carboxylated polystyrene microspheres with sulfonyl fluoride groups.
- 300 μl, (32 million microspheres) of a carboxylated polystyrene microsphere solution (5.5 μm) was washed two times with 500 μL of DI water, two times with 500 μL of methanol, and two times with 500 μL of benzene using centrifugation at 13,400×g for 1 minute to pellet the microspheres and 20 seconds of sonication to resuspend the microspheres. The microspheres were then suspended in a solution of 50 μL thionyl chloride in 250 μL of benzene and kept at 40° C. for 2 hours. Then they were washed three times with 500 μL of benzene and two times with 500 μL of acetonitrile and afterwards suspended in a solution of 12 mg of potassium 7-amino-1,3-disulfonylnaphthalene in 500 μL of acetonitrile and placed in a shaker at room temperature. After 14 hours the microspheres were washed two times with 500 μL of acetonitrile. The 5868-03807 microspheres were suspended in a solution of acetonitrile containing 15 μL of cyanuric fluoride and 20 μL of pyridine and kept at −15° C. for 14 hours and afterwards washed three times with 500 μL of acetonitrile. The microspheres were suspended and stored in 1 mL of acetonitrile. The just described procedure is graphically described in Entry 2b of Table 1.
- 7.0.3 Mono-fluoro Squaric Acid (MFS)
- The following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention. In particular, the following example describes a method for activating carboxylated polystyrene microspheres with mono-fluoro squaric acid groups using adipic acid dihydrazide as a linker.
- 300 μL (32 million microspheres) of a carboxylated polystyrene microsphere solution (5.5 μm) was washed three times with 500 μL of a solution containing 0.01
% Tween 20 and 0.1 M MES buffer, pH 6.0 using centrifugation at 13,400×g for 1 minute to pellet the microspheres and 20 seconds of sonication to resuspend the microspheres. The microspheres were then suspended in 500 μL of a solution containing 32 mg/mL of ADH (adipic acid dihydrazide) and 2 g/mL of EDC, 0.0 1% Tween 20, and 0.1M MES buffer, pH 6.0 and placed on a rotating mixer for 2 hours protected from light. The microspheres were washed three times with 500 μL of water, three times with 500 μL of methanol, and three times with 500 μL of benzene. The microspheres were then suspended in 500 μL of benzene and 14, of dibutoxy cyclobutene dione was added. After shaking on a thermal shaker for 14 hours at 25° C., the microspheres were washed three times with 500 μL of benzene, three times with 500 μL of methanol, and three times with 500 μL of DI water. To the microspheres was added 500 μL of a 1M solution of sodium hydroxide. The microspheres were then placed in a thermal shaker for 2 hours at 60° C. Then they were washed with 500 μL of methanol to recover the microspheres. The microspheres were then washed with 500 μL of a 2 M solution of hydrochloric acid. Methanol was added to recover the microspheres. The microspheres were then washed three times with 500 μl, of methanol and three times with 500 μL of acetonitrile. The microspheres were then suspended in 500 μL of acetonitrile. A solution of 15 μL of cyanuric fluoride and 20 μL of pyridine was added and then the microspheres were stored at −15° C. for 14 hours. The microspheres were then washed three times with 500 μL of acetonitrile. The microspheres were suspended and stored in 1 mL of acetonitrile. The just described procedure is graphically described in Entry 3c of Table 1. - 7.0.4 Cyanuric Fluoride
- The following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention. In particular, the following example describes a method for activating carboxylated polystyrene microspheres with cyanuric fluoride using 1,6-diaminohexane as a linker.
- 300 μL (32 million microspheres) of carboxylated polystyrene microsphere solution (5.5 μm) was washed three times with 500 μL of a solution containing 0.01
% Tween 20 and 0.1M MES buffer, pH 6.0 using centrifugation at 13,400×g for 1 minute to pellet the microspheres and 20 seconds of sonication to resuspend the microspheres. Afterwards they were suspended in 500 μL of a solution containing 32 mg/mL of 1,6-diaminohexane and 2 g/mL of EDC, 0.01% Tween 20, and 0.1M MES buffer, pH 6.0 and placed on a rotating mixer for 2 hours protected from light. Subsequently the microspheres were washed three times with 500 μL of water, three times with 500 μL of methanol, and three times with 500 μL of acetonitrile. The microspheres were then suspended in a solution containing 500 μl, of acetonitrile, 20 μL of trimethyl amine and 15 μL of cyanuric fluoride and was set for 14 hours at −15° C. Finally they were washed three times with acetonitrile. The microspheres were suspended and stored in 1 mL of acetonitrile. The just described procedure is graphically described in Entry 4 of Table 1. - 7.0.5 Vinyl Sulfone (VS)
- The following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention. In particular, the following example describes a method for activating carboxylated polystyrene microspheres with vinyl sulfone (VS) using 2-aminoethanethiol as a linker.
- 300 μL (32 million microspheres) of a carboxylated polystyrene microsphere solution (5.5 μm) was washed three times with 500 μL of 0.1M MES buffer, pH 6.0 including 0.01
% Tween 20 using centrifugation at 13,400×g for 1 minute to pellet the microspheres and 20 seconds of sonication to resuspend the microspheres. Subsequently the microspheres were suspended in 500 μL of a 16 mg /mL solution of cysteamine and 30 mg/mL solution of EDC in 0.01% Tween 20, 0.1M MES buffer, pH 6.0 and placed on a rotating mixer protected from light for 2 hours. The microspheres were washed three times with 500 μL of water and three times with 500 μL of 0.1M sodium chloride/0.1M sodium acetate buffer, pH 4.5. The disulfide bonds of the bound cysteamine groups were reduced by suspending the microspheres in 500 μL of a 11 mg/mL solution of dithiothreitol (DTT) in 0.1M sodium acetate/0.1M sodium chloride buffer, pH 4.5. The microspheres were placed on a rotating mixer for 30 minutes and afterwards washed three times with 500 μl, of methanol. Then they were suspended in 500 μL of dichloromethane and 5 μL of vinyl sulfone (VS) was added. After mixing on a rotating mixer for 14 hours, 500 μL of methanol was added and the microspheres were recovered and washed three times with 500 mL of methanol. The microspheres were suspended and stored in 1 mL of methanol. The just described procedure is graphically described in Entry 5b of Table 1. - 7.0.6 Protected Vinyl Sulfone
- The following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention. In particular, the following example describes a method for converting the activated polystyrene microspheres of the previous example into a more hydrolysis resistant form.
- Microspheres prepared according to Example 5.0.5 were suspended in 800 μL of a solution containing 3 mg of sodium thiosulfite, 0.01
% Tween 20, and sodium phosphate buffer, pH 4.0 for 14 hours. The microspheres were washed three times with 500 μL of DI water. The microspheres were suspended and stored in 1 mL of DI water. The microspheres are not reactive with nucleophiles unless they are first treated with a buffer of pH 9-10. The just described procedure is graphically described in Entry 5c of Table 1. - 7.0.7 Tetra-fluoro sulfo-phenyl Ester (TFS)
- The following describes a method for the preparation of an activated surface capable of immobilizing a biomolecule in accordance with the present invention. In particular, the following example describes a method for directly activating carboxylated polystyrene microspheres with tetra-fluoro sulfophenyl esters.
- 300 μL (32 million microspheres) of a carboxylated polystyrene microsphere solution (5.5 μm) was washed three times with 500 μL of a solution containing 0.01
% Tween 20 and 0.1 M MES buffer, pH 6.0 using centrifugation at 13,400×g for 1 minute to pellet and 20 seconds of sonication to resuspend the microspheres. Then they were suspended in 500 μL of a solution containing 24 mg/mL of 2,3,5,6 tetrafluorophenol-4-sulfate (synthesized from 2,3,5,6 tetrafluorophenol according to the procedure of Gee, K. R. et al., Tetrahedron Lett., 1999, 40, 1472-1474), 220 mg/mL of EDC, 0.01% Tween 20, and 0.1M MES buffer, pH 6.0 and then placed on a rotating mixer protected from light for 2 hours. The microspheres were washed three times with 500 μL of DI water. The microspheres were suspended and stored in 1 mL of DI water. The just described procedure is graphically described in Entry 6 of Table 1. - 7.1 Examples of Novel Reactive Group Evaluation
- In order to quantify the reactivity of the different novel reactive functional groups on polystyrene microspheres, a simple assay was developed using a biotin-amine derivative. First, biotin-LC-PEO-amine (obtained from Pierce, Rockford, Ill.) was coupled to carboxylated microspheres using typical EDC-mediated methods, followed by reaction with streptavidin-PE. The optimum concentrations of both biotin-amine and streptavidin-PE (obtained from Molecular Probes, Eugene, Oreg.) were titrated. This coupling assay provided a “standard” by which to measure and compare the reactivity of microspheres modified with the novel reactive functional groups. The modified microspheres are evaluated by reacting the biotin-amine directly, followed by reaction with streptavidin-PE. Functional group stability was evaluated by storing the microspheres either in buffer (pH 6; 4° C.) or dry, and performing the biotin-LC-PEO-amine assay at set intervals (e.g., days, weeks, months, etc.).
- According to our test results our new novel reactive groups exhibit very desirable properties. For example, novel reactive groups show good reactivity with nucleophilic compounds, have substantially improved stability in aqueous media, form stable conjugates, require no additional activating reagents (e.g., EDC and/or NHS esters), and may provide more specific conjugation (i.e., reduce non-specific interaction/binding with solid substrates) thus protecting the integrity of biomolecules.
- 7.1.1 Coupling Reactivity and Reproducibility
- An accelerated stability study comparing the EDC-mediated coupling method to mono-fluoro squaric acid (MFS)-modified microspheres was carried out over an equivalent of 350 days. Using the biotin-amine model assay, results showed comparable reactivity between the two methods. Results also show the mono-fluoro squaric acid (MFS)-modified microspheres provide more reproducible coupling day-to-day. As depicted in
FIG. 1 , the EDC coupling method showed 20% changes in coupling throughout the entire experiment. During the equivalent 350 days, the mono-fluoro squaric acid (MFS)-modified microspheres lost some activity gradually, retaining 80% activity at the end of the study (i.e., the greatest change in activity was shown at the end of 350 equivalent days). Improvements in storage procedures are expected to eliminate any loss of activity for modified microspheres. - 7.1.2 Stability
- Results show that microspheres modified with novel reactive groups have substantially improved stability in aqueous media.
FIG. 2 depicts an example of the stability of vinyl-sulfone (VS)-functionalized microspheres in buffer for at least 30 days. This is a substantial improvement compared to EDC and NHS reagents, however, since there is a trade-off between reactivity and stability, we have also evaluated various drying and storage methods for long-term storage (including for example, 6 months, ≧approximately 6 months, greater than six months, six months to nine months, six months to one year, six months to two years, etc.) of the modified microspheres.FIGS. 3-6 depict examples of dry storage condition stability studies. Storage vessels that provide superior moisture barrier properties to those used in this study, will prevent loss of activity over time. - 7.1.3 Bioassays
- The performance of modified microspheres in real assays compared to the COOH microsphere-EDC method was evaluated.
FIG. 7 shows a coupling titration of an amino-modified DNA probe on COOH-functionalized microspheres (EDC-mediated reaction) vs. pre-activated microsphere method. Both coupling titrations were performed at 25° C. The DNA compliment target concentration for the assay was 20 fmoles at a hybridization temperature of 55° C. Results show the COOH-EDC method yields a non-linear response to the amount of probe coupled to the microsphere. The pre-activated microsphere probe titration is more linear, suggesting a more specific coupling of the probe. Both results are reproducible. Note: 25° C. is not an optimal coupling temperature for the pre-activated microspheres. The signal is expected to improve with optimization of coupling temperature, as well as other parameters. - 7.2 Examples of Coupling Procedures
- 7.2.1 Biotin-LC-PEO Amine
- Surface-modified microspheres were washed three times with phosphate buffer (
pH 6, 100 mM) and counted. 2.5×107 microspheres were aliquoted and washed once with phosphate buffer (pH 8, 100 mM). A solution of PEO-LC-biotin-amine (17.4 mg/mL) was prepared in phosphate buffer (pH 8, 100 mM). 100 μL of this solution was added to the microspheres, in 900 μL phosphate buffer (pH 8, 100 mM). The suspension was incubated at 37° C. for 1 hour. After the reaction was complete, the microspheres were washed three times with PBS-TBN (phosphate buffered saline, pH 7.4 with 0.02% Tween 20 and 1 g/L bovine serum albumin), and recounted. A suspension of 100,000 microspheres/mL PBS-TBN was reacted with 1 μg Streptavidin-PE for 1 hour at room temperature. Subsequently the microspheres were washed three times and resuspended in 1 mL PBS-TBN. The fluorescence intensity of the microspheres was analyzed on aLuminex 100™ instrument. - 7.2.2 Biotinylated IgG
- A suspension of 25×106 surface-modified microspheres was washed with 1 mL carbonate buffer (
pH 9, 100 mM). A 1 mL solution of IgG (50 μg/mL in 0.1M pH 9 carbonate buffer) was added to the microspheres, vortexed, sonicated and incubated at 37° C. for 1 hour. After 1 hour, the sample was washed with 1 mL PBS-TBN (phosphate buffered saline, pH 7.4 with 0.02% Tween 20 and 1 g/L bovine serum albumin). A suspension of 100,000 microspheres/mL PBS-TBN was reacted with 1 μg Streptavidin-PE for 1 hour at room temperature. Subsequently the microspheres were washed three times and resuspended in 1 mL PBS-TBN. The fluorescence intensity of the microspheres was analyzed on aLuminex 100™ instrument. - 7.2.3 Biotinylated Oligonucleotides
- 5×106 surface-modified microspheres were dispensed into a 1.5 ml centrifuge tube and washed with 1 mL of carbonate buffer (
pH 9, 100 mM). 50 μL, carbonate buffer (pH 9, 100 mM) was added to the microspheres. 1 μL of a 1 mM solution of amino-modified oligonucleotide was added and the suspension was incubated at 37° C. for 1 hour. After 1 hour the sample was washed with PBS-TBN. A suspension of 100,000 microspheres/mL PBS-TBN was reacted with 1 μg Streptavidin-PE for 1 hour at room temperature. Subsequently the microspheres were washed three times and resuspended in 1 mL PBS-TBN. The fluorescence intensity of the microspheres was analyzed on aLuminex 100™ instrument. - Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/119,203 US8188269B1 (en) | 2001-11-14 | 2008-05-12 | Functionalized compositions for improved immobilization |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33131201P | 2001-11-14 | 2001-11-14 | |
US10/293,260 US7241883B2 (en) | 2001-11-14 | 2002-11-14 | Functionalized compositions for improved immobilization |
US11/621,209 US7385053B2 (en) | 2001-11-14 | 2007-01-09 | Functionalized compositions for improved immobilization |
US12/119,203 US8188269B1 (en) | 2001-11-14 | 2008-05-12 | Functionalized compositions for improved immobilization |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/621,209 Division US7385053B2 (en) | 2001-11-14 | 2007-01-09 | Functionalized compositions for improved immobilization |
Publications (2)
Publication Number | Publication Date |
---|---|
US20120123026A1 true US20120123026A1 (en) | 2012-05-17 |
US8188269B1 US8188269B1 (en) | 2012-05-29 |
Family
ID=28791841
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/293,260 Active 2024-09-20 US7241883B2 (en) | 2001-11-14 | 2002-11-14 | Functionalized compositions for improved immobilization |
US11/621,209 Expired - Lifetime US7385053B2 (en) | 2001-11-14 | 2007-01-09 | Functionalized compositions for improved immobilization |
US12/119,203 Active 2025-10-01 US8188269B1 (en) | 2001-11-14 | 2008-05-12 | Functionalized compositions for improved immobilization |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/293,260 Active 2024-09-20 US7241883B2 (en) | 2001-11-14 | 2002-11-14 | Functionalized compositions for improved immobilization |
US11/621,209 Expired - Lifetime US7385053B2 (en) | 2001-11-14 | 2007-01-09 | Functionalized compositions for improved immobilization |
Country Status (6)
Country | Link |
---|---|
US (3) | US7241883B2 (en) |
EP (1) | EP1476753B1 (en) |
JP (1) | JP4598403B2 (en) |
AU (1) | AU2002367639A1 (en) |
CA (1) | CA2464144A1 (en) |
WO (1) | WO2003084982A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9597672B2 (en) | 2011-03-10 | 2017-03-21 | Cornell University | Mesoporous catalysts of magnetic nanoparticles and free-radical-producing enzymes, and methods of use |
US10792649B2 (en) | 2015-07-15 | 2020-10-06 | Zymtronix, Llc | Automated bionanocatalyst production |
US10881102B2 (en) | 2015-05-18 | 2021-01-05 | Zymtronix, Llc | Magnetically immobilized microbiocidal enzymes |
US10993436B2 (en) | 2016-08-13 | 2021-05-04 | Zymtronix Catalytic Systems, Inc. | Magnetically immobilized biocidal enzymes and biocidal chemicals |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7241883B2 (en) * | 2001-11-14 | 2007-07-10 | Luminex Corporation | Functionalized compositions for improved immobilization |
US20040258614A1 (en) * | 2003-06-20 | 2004-12-23 | University Of Maryland, Baltimore | Microparticles for microarterial imaging and radiotherapy |
WO2005047900A1 (en) * | 2003-10-15 | 2005-05-26 | Q-Rna, Inc. | Prion protein dye conjugates and methods of use |
US7169933B2 (en) | 2003-11-14 | 2007-01-30 | 3M Innovative Properties Company | N-sulfonylaminocarbonyl containing compounds |
US7423155B2 (en) | 2003-11-14 | 2008-09-09 | 3M Innovative Properties Company | N-sulfonyldicarboximide containing tethering compounds |
KR101130956B1 (en) | 2003-11-14 | 2012-03-30 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | N-sulfonylaminocarbonyl containing compounds |
US7361767B2 (en) | 2003-11-14 | 2008-04-22 | 3M Innovative Properties Company | N-sulfonyldicarboximide containing tethering compounds |
US7943388B2 (en) | 2003-11-14 | 2011-05-17 | 3M Innovative Properties Company | Acoustic sensors and methods |
JP4639062B2 (en) * | 2003-11-21 | 2011-02-23 | 富士フイルム株式会社 | Photosensitive composition, compound used for photosensitive composition, and pattern formation method using the photosensitive composition |
JP4752318B2 (en) * | 2004-04-30 | 2011-08-17 | 住友化学株式会社 | Polymer having oxocarbon group and use thereof |
EP1741740A4 (en) * | 2004-04-30 | 2009-07-01 | Sumitomo Chemical Co | Polymer having oxocarbon group and use thereof |
US8048940B2 (en) * | 2004-07-09 | 2011-11-01 | Vanderbilt University | Reactive graphitic carbon nanofiber reinforced polymeric composites showing enhanced flexural strength |
JP4617112B2 (en) * | 2004-08-03 | 2011-01-19 | 富士フイルム株式会社 | Photosensitive composition, compound used for photosensitive composition, and pattern formation method using the photosensitive composition |
US8088629B1 (en) | 2004-10-12 | 2012-01-03 | Luminex Corporation | Methods for forming dyed microspheres and populations of microspheres |
DE602005021135D1 (en) * | 2004-10-12 | 2010-06-17 | Luminex Corp | PROCESS FOR CHANGING THE SURFACE PROPERTIES OF MICRO BEADS |
EP1815249A4 (en) * | 2004-11-26 | 2009-06-24 | Texas A & M Univ Sys | Immunologic assay for detection of autoantibodies to folate binding protein |
US7544754B2 (en) | 2005-09-30 | 2009-06-09 | 3M Innovative Properties Company | Crosslinked polymers with amine binding groups |
US7544756B2 (en) | 2005-09-30 | 2009-06-09 | 3M Innovative Properties Company | Crosslinked polymers with amine binding groups |
US7544755B2 (en) | 2005-09-30 | 2009-06-09 | 3M Innovative Properties Company | Crosslinked polymers with amine binding groups |
US20100209946A1 (en) * | 2007-04-19 | 2010-08-19 | Naiyong Jing | Uses of water-dispersible silica nanoparticles for attaching biomolecules |
US8597959B2 (en) * | 2007-04-19 | 2013-12-03 | 3M Innovative Properties Company | Methods of use of solid support material for binding biomolecules |
US8138231B2 (en) * | 2007-10-29 | 2012-03-20 | Sumitomo Chemical Company, Limited | Polymer having oxycarbon group, and use thereof |
ES2325293B1 (en) * | 2008-02-28 | 2010-06-04 | Universidad De Granada | SIMPLE LABELING AGENTS BASED ON VINILSULFONA. |
WO2010054385A2 (en) | 2008-11-10 | 2010-05-14 | Luminex Corporation | Method and system for manufacture and use of macroporous beads in a multiplex assay |
US20120187373A1 (en) * | 2011-01-24 | 2012-07-26 | Brookhaven Science Associates, Llc | Stepwise Surface Assembly of Quantum Dot-Fullerene Heterodimers |
US9139667B2 (en) | 2012-02-09 | 2015-09-22 | Life Technologies Corporation | Conjugated polymeric particle and method of making same |
US9512163B2 (en) * | 2012-05-21 | 2016-12-06 | Agilent Technologies, Inc. | Compositions and methods for conjugating oligonucleotides |
US10144968B2 (en) | 2015-07-02 | 2018-12-04 | Life Technologies Corporation | Conjugation of carboxyl functional hydrophilic beads |
EP3320115B1 (en) | 2015-07-06 | 2020-09-02 | Life Technologies Corporation | Substrates and methods useful in sequencing |
EP3184674A1 (en) * | 2015-12-23 | 2017-06-28 | Technische Universität Dortmund | Dna-encoded chemical library, use thereof and method to synthesize the library |
CN111137985B (en) * | 2020-01-08 | 2022-07-08 | 西南科技大学 | Preparation method of microbial degradation material for treating ammonia nitrogen in sewage |
CN114507722A (en) * | 2020-11-16 | 2022-05-17 | 深圳市真迈生物科技有限公司 | Compound modified chip and preparation method and application thereof |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE960534C (en) | 1950-01-09 | 1957-03-21 | Hoechst Ag | Process for the production of real colors and prints |
NL290658A (en) | 1962-04-24 | |||
US5414135A (en) * | 1991-12-30 | 1995-05-09 | Sterling Winthrop Inc. | Vinyl sulfone coupling of polyoxyalkylenes to proteins |
JPH0649100A (en) * | 1992-05-06 | 1994-02-22 | Eastman Kodak Co | Method for bonding compound to carboxylated base |
DE69402013T2 (en) | 1993-08-30 | 1997-06-19 | Eastman Kodak Co | Process for the preparation of compounds having two or more vinyl sulfone groups |
DE4341524C2 (en) * | 1993-12-06 | 1997-01-16 | Gluesenkamp Karl Heinz Dr | Process for immobilizing biomolecules and affinity ligands on polymeric supports |
US5981180A (en) * | 1995-10-11 | 1999-11-09 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
US5736330A (en) * | 1995-10-11 | 1998-04-07 | Luminex Corporation | Method and compositions for flow cytometric determination of DNA sequences |
US6449562B1 (en) * | 1996-10-10 | 2002-09-10 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
US6146833A (en) * | 1997-02-11 | 2000-11-14 | Beckman Coulter, Inc. | Polymeric reagents for immobilizing biopolymers |
AU8148898A (en) * | 1997-06-23 | 1999-01-04 | Luminex Corporation | Interlaced lasers for multiple fluorescence measurement |
ATE239801T1 (en) * | 1998-01-22 | 2003-05-15 | Luminex Corp | MICROPARTICLES WITH MULTIPLE FLUORESCENCE SIGNALS |
CA2331896C (en) * | 1998-05-14 | 2009-09-15 | Luminex Corporation | Diode laser based measurement apparatus |
US6411904B1 (en) * | 1998-05-14 | 2002-06-25 | Luminex Corporation | Zero dead time architecture for flow cytometer |
EP1089988B1 (en) | 1998-06-24 | 2009-08-12 | Aventis Pharmaceuticals Inc. | Fluorophenyl resin compounds |
JP2000088853A (en) * | 1998-07-14 | 2000-03-31 | Jsr Corp | Particle for diagnostics |
CA2346871A1 (en) * | 1998-10-16 | 2000-04-27 | Amersham Pharmacia Biotech Ab | Squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
DE19850680A1 (en) * | 1998-11-03 | 2000-05-04 | Peter Nehls | Method for determining the repair capacity of solutions containing DNA repair enzymes and for detecting DNA structural modifications and base mismatches |
SE520256C2 (en) * | 2001-10-25 | 2003-06-17 | Lundonia Biotech Ab | Biomolekylkvadratsyramonoamidkopplingsreagensintermediär |
US7241883B2 (en) * | 2001-11-14 | 2007-07-10 | Luminex Corporation | Functionalized compositions for improved immobilization |
US8090172B2 (en) | 2007-09-12 | 2012-01-03 | Siemens Medical Solutions Usa, Inc. | Robust segmentation of breast and muscle in MRI |
-
2002
- 2002-11-14 US US10/293,260 patent/US7241883B2/en active Active
- 2002-11-14 EP EP02806781.7A patent/EP1476753B1/en not_active Expired - Lifetime
- 2002-11-14 AU AU2002367639A patent/AU2002367639A1/en not_active Abandoned
- 2002-11-14 JP JP2003582178A patent/JP4598403B2/en not_active Expired - Fee Related
- 2002-11-14 CA CA002464144A patent/CA2464144A1/en not_active Abandoned
- 2002-11-14 WO PCT/US2002/036458 patent/WO2003084982A2/en active Application Filing
-
2007
- 2007-01-09 US US11/621,209 patent/US7385053B2/en not_active Expired - Lifetime
-
2008
- 2008-05-12 US US12/119,203 patent/US8188269B1/en active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9597672B2 (en) | 2011-03-10 | 2017-03-21 | Cornell University | Mesoporous catalysts of magnetic nanoparticles and free-radical-producing enzymes, and methods of use |
US10260061B2 (en) | 2011-03-10 | 2019-04-16 | Cornell University | Mesoporous catalysts of magnetic nanoparticles and free-radical-producing enzymes, and methods of use |
US10316313B2 (en) | 2011-03-10 | 2019-06-11 | Cornell University | Mesoporous catalysts of magnetic nanoparticles and free-radical-producing enzymes, and methods of use |
US10881102B2 (en) | 2015-05-18 | 2021-01-05 | Zymtronix, Llc | Magnetically immobilized microbiocidal enzymes |
US11517014B2 (en) | 2015-05-18 | 2022-12-06 | Zymtronix, Inc. | Magnetically immobilized microbiocidal enzymes |
US10792649B2 (en) | 2015-07-15 | 2020-10-06 | Zymtronix, Llc | Automated bionanocatalyst production |
US10993436B2 (en) | 2016-08-13 | 2021-05-04 | Zymtronix Catalytic Systems, Inc. | Magnetically immobilized biocidal enzymes and biocidal chemicals |
Also Published As
Publication number | Publication date |
---|---|
EP1476753B1 (en) | 2013-08-14 |
US20080103061A1 (en) | 2008-05-01 |
WO2003084982A2 (en) | 2003-10-16 |
AU2002367639A1 (en) | 2003-10-20 |
AU2002367639A8 (en) | 2003-10-20 |
US7385053B2 (en) | 2008-06-10 |
US7241883B2 (en) | 2007-07-10 |
JP4598403B2 (en) | 2010-12-15 |
US8188269B1 (en) | 2012-05-29 |
EP1476753A2 (en) | 2004-11-17 |
JP2005532533A (en) | 2005-10-27 |
WO2003084982A3 (en) | 2004-09-10 |
CA2464144A1 (en) | 2003-10-16 |
US20040039201A1 (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8188269B1 (en) | Functionalized compositions for improved immobilization | |
Liu et al. | Oriented immobilization of proteins on solid supports for use in biosensors and biochips: a review | |
Matsuya et al. | A Core− Shell-type fluorescent Nanosphere possessing reactive poly (ethylene glycol) tethered chains on the surface for Zeptomole detection of protein in time-resolved Fluorometric immunoassay | |
JP2536995B2 (en) | Enzyme immobilization method | |
Camarero et al. | Chemoselective attachment of biologically active proteins to surfaces by expressed protein ligation and its application for “protein chip” fabrication | |
JP2005532533A5 (en) | ||
Witus et al. | Identification of highly reactive sequences for PLP-mediated bioconjugation using a combinatorial peptide library | |
US20110086431A1 (en) | Methods for Altering Surface Characteristics of Microspheres | |
Ha et al. | Oriented immobilization of antibodies with GST-fused multiple Fc-specific B-domains on a gold surface | |
Ho et al. | A metal-chelating pluronic for immobilization of histidine-tagged proteins at interfaces: immobilization of firefly luciferase on polystyrene beads | |
Generalova et al. | Submicron polymer particles containing fluorescent semiconductor nanocrystals CdSe/ZnS for bioassays | |
Sapsford et al. | Surface-immobilized self-assembled protein-based quantum dot nanoassemblies | |
US9422371B2 (en) | Surface-bound fluorinated esters for amine capture | |
CN102313725A (en) | Preparation method of lysozyme molecular imprinting-quantum dot nanoscale fluorescent probe | |
Engin et al. | SNAP-tag as a tool for surface immobilization | |
US9575069B2 (en) | Use of antibody-surrogate antigen systems for detection of analytes | |
Korten et al. | Selective control of gliding microtubule populations | |
JP4107873B2 (en) | Luminescent fine particles | |
Kant et al. | Relevance of adhesion in fabrication of microarrays in clinical diagnostics | |
Iversen et al. | Templated protein assembly on micro-contact-printed surface patterns. Use of the SNAP-tag protein functionality | |
Lee et al. | High-yielding and photolabile approaches to the covalent attachment of biomolecules to surfaces via hydrazone chemistry | |
KR100877187B1 (en) | Protein chip and detection method of the same comprising protein nanoparticles linked with epitope recognizing disease marker for diagnosis | |
US20050192430A1 (en) | Linker arms for nanocrystals and compounds thereof | |
Miller et al. | Biomolecular screening with novel organosilica microspheres | |
JPH0727767A (en) | Coating carrier, manufacture thereof, and usage to fixation onto solid surface of biological molecule thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LUMINEX CORPORATION, TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LUGADE, ANANDA G.;HOFFACKER, KURT D.;JENKINS, ADAM J.;AND OTHERS;SIGNING DATES FROM 20030318 TO 20030506;REEL/FRAME:020936/0174 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |